BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275-8. [PMID: 11815495 DOI: 10.2337/diacare.25.2.275] [Cited by in Crossref: 692] [Cited by in F6Publishing: 715] [Article Influence: 33.0] [Reference Citation Analysis]
Number Citing Articles
1 Shin A, Connolly S, Kabytaev K. Protein glycation in diabetes mellitus. Adv Clin Chem 2023;113:101-56. [PMID: 36858645 DOI: 10.1016/bs.acc.2022.11.003] [Reference Citation Analysis]
2 Al-Kafaween MA, Alwahsh M, Mohd Hilmi AB, Abulebdah DH. Physicochemical Characteristics and Bioactive Compounds of Different Types of Honey and Their Biological and Therapeutic Properties: A Comprehensive Review. Antibiotics (Basel) 2023;12. [PMID: 36830249 DOI: 10.3390/antibiotics12020337] [Reference Citation Analysis]
3 Langhinrichsen-Rohling J, Richie F, Kelley M, Selwyn C, Archer S, Blejwas E. Charitable Pharmacies as Catalysts for Coordinated Care: Pharmacist Management of Blood Glucose Among Under-Resourced Patients With Type 2 Diabetes. Health Promot Pract 2023;:15248399221115082. [PMID: 36627769 DOI: 10.1177/15248399221115082] [Reference Citation Analysis]
4 John J, Sakarde A, Chafle J, Amle D, Jose J, Sakhare V, Rathod BD. An Assessment of the Utility of Serum Fructosamine in the Diagnosis and Monitoring of Diabetes Mellitus. Cureus 2023;15:e33549. [PMID: 36779109 DOI: 10.7759/cureus.33549] [Reference Citation Analysis]
5 Sur T, Das A, Bashar S, Tarafdar S, Sarkar B, Madhu NR. Biochemical Assay for Measuring Diabetes Mellitus. Advances in Diabetes Research and Management 2023. [DOI: 10.1007/978-981-19-0027-3_1] [Reference Citation Analysis]
6 Abdel Bagi O, Ewis A. Assessment of Glycemic Control in Patients With Diabetes in Northern Sudan Using Calculated HbA1c. Cureus 2022;14:e33080. [PMID: 36721598 DOI: 10.7759/cureus.33080] [Reference Citation Analysis]
7 Fallah F, Alijanpour M, Khafri S, Pournasrollah M, Talebi GA. The effect of neuromuscular electrical stimulation on serum glucose levels in children and adolescents with type-1 diabetes mellitus: a single group clinical trial. BMC Endocr Disord 2022;22:246. [PMID: 36221091 DOI: 10.1186/s12902-022-01149-6] [Reference Citation Analysis]
8 Yang G, Au Yeung SL, Schooling CM. Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: A Mendelian randomization study. EBioMedicine 2022;84:104259. [PMID: 36179552 DOI: 10.1016/j.ebiom.2022.104259] [Reference Citation Analysis]
9 Xie X, Bai G, Zhang L, Liu H, Qiang D, Li L. Changes in plasma IRAK-M in patients with prediabetes and its relationship with related metabolic indexes: a cross-sectional study. J Int Med Res 2022;50:3000605221111275. [PMID: 36039603 DOI: 10.1177/03000605221111275] [Reference Citation Analysis]
10 Yildiz AS, Ustundag FD, Tiber PM, Dogan B. The relationship between vitamin D receptor gene polymorphisms and periodontitis in turkish individuals with type 2 diabetes mellitus. Niger J Clin Pract 2022;25:1163-72. [PMID: 35859479 DOI: 10.4103/njcp.njcp_1894_21] [Reference Citation Analysis]
11 Shimizu N, Ogawa A, Hayashi A, Shichiri M. Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitors. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108225] [Reference Citation Analysis]
12 Husted KLS, Brink-Kjær A, Fogelstrøm M, Hulst P, Bleibach A, Henneberg KÅ, Sørensen HBD, Dela F, Jacobsen JCB, Helge JW. A Model for Estimating Biological Age From Physiological Biomarkers of Healthy Aging: Cross-sectional Study. JMIR Aging 2022;5:e35696. [PMID: 35536617 DOI: 10.2196/35696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Brun C, Hernandez-Alba O, Hovasse A, Criscuolo F, Schaeffer-Reiss C, Bertile F. Resistance to glycation in the zebra finch: Mass spectrometry-based analysis and its perspectives for evolutionary studies of aging. Exp Gerontol 2022;164:111811. [PMID: 35472570 DOI: 10.1016/j.exger.2022.111811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 . Bibliography. Applied Biostatistics for the Health Sciences 2022. [DOI: 10.1002/9781119722717.biblio] [Reference Citation Analysis]
15 . Implant Therapy. Peri‐Implant Therapy for the Dental Hygienist 2022. [DOI: 10.1002/9781119766247.ch2] [Reference Citation Analysis]
16 Ibrahim AM, Lawrence S, Tobón GJ. Improving Diabetes Care: A Fijian Diabetes Service Improvement Study. International Journal of Chronic Diseases 2022;2022:1-9. [DOI: 10.1155/2022/9486679] [Reference Citation Analysis]
17 Juhász I, Juhász J, Lörincz H, Seres I, Végh L, Ujfalusi S, Harangi M, Szabó Z, Paragh G, Kam CW. The Potential Diagnostic and Predictive Role of HbA1c in Diabetic, Septic Patients: A Retrospective Single-Center Study. Emergency Medicine International 2022;2022:1-11. [DOI: 10.1155/2022/8543232] [Reference Citation Analysis]
18 Valenzano M, Cibrario Bertolotti I, Grassi G, Broglio F, Valenzano A. Predicting Glycated Hemoglobin Through Continuous Glucose Monitoring in Real-Life Conditions: Improved Estimation Methods. J Diabetes Sci Technol. [DOI: 10.1177/19322968221081556] [Reference Citation Analysis]
19 Dominguez-riscart J, Buero-fernandez N, Garcia-zarzuela A, Morales-perez C, Garcia-ojanguren A, Lechuga-sancho AM. Adherence to Mediterranean Diet Is Associated With Better Glycemic Control in Children With Type 1 Diabetes: A Cross-Sectional Study. Front Nutr 2022;9:813989. [DOI: 10.3389/fnut.2022.813989] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Sriwimol W, Choosongsang P, Choosongsang P, Petkliang W, Treerut P. Associations between HbA1c-derived estimated average glucose and fasting plasma glucose in patients with normal and abnormal hemoglobin patterns. Scand J Clin Lab Invest 2022;:1-7. [PMID: 35175156 DOI: 10.1080/00365513.2022.2040051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Quigley M, Earnest A, Szwarcbard N, Wischer N, Andrikopoulos S, Green S, Zoungas S. Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors. PLoS ONE 2022;17:e0263511. [DOI: 10.1371/journal.pone.0263511] [Reference Citation Analysis]
22 Prakash N, Melath A, Subair K, Arjun M. A bridge between diabetes and periodontitis. Int J Med Oral Res 2022;7:45. [DOI: 10.4103/ijmo.ijmo_14_22] [Reference Citation Analysis]
23 Xie X, Bai G, Qiang D, Zhang L, Liu H, He YT, Zhang X, Couillard C. Changes in serum copeptin in the early onset of type 2 diabetes. FACETS 2022;7:1244-57. [DOI: 10.1139/facets-2022-0019] [Reference Citation Analysis]
24 Williams ME, Stanton RC. Nutritional and metabolic management of the diabetic patient with chronic kidney disease and chronic renal failure. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00006-9] [Reference Citation Analysis]
25 Selvi NMK, Nandhini S, Sakthivadivel V, Lokesh S, Srinivasan AR, Sumathi S. Association of Triglyceride-Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus. Maedica (Bucur) 2021;16:375-81. [PMID: 34925590 DOI: 10.26574/maedica.2021.16.3.375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Husted KLS, Brink-kjær A, Fogelstrøm M, Hulst P, Bleibach A, Henneberg K, Sørensen HBD, Dela F, Jacobsen JCB, Helge JW. A Model for Estimating Biological Age From Physiological Biomarkers of Healthy Aging: Cross-sectional Study (Preprint).. [DOI: 10.2196/preprints.35696] [Reference Citation Analysis]
27 Liu F, Sirisena S, Ng K. Efficacy of flavonoids on biomarkers of type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr 2021;:1-27. [PMID: 34842001 DOI: 10.1080/10408398.2021.2009761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Hummel B, Yerkes MA, Harskamp RE, Galenkamp H, Kunst AE, Lok A, van Valkengoed IG. The COVID-19 pandemic and temporal change in metabolic risk factors for cardiovascular disease: a natural experiment within the HELIUS study.. [DOI: 10.1101/2021.11.25.21266856] [Reference Citation Analysis]
29 Ates KM, Estes AJ, Liu Y. Potential underlying genetic associations between keratoconus and diabetes mellitus. Adv Ophthalmol Pract Res 2021;1:100005. [PMID: 34746916 DOI: 10.1016/j.aopr.2021.100005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
30 Wang Z, Liu Y, Xie J, Liu NF. Association between hemoglobin glycation index and subclinical myocardial injury in the general population free from cardiovascular disease. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00516-0. [PMID: 34895803 DOI: 10.1016/j.numecd.2021.10.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Jeyafzam F, Vaziri B, Suraki MY, Hosseinabadi AAR, Slowik A. Improvement of grey wolf optimizer with adaptive middle filter to adjust support vector machine parameters to predict diabetes complications. Neural Comput & Applic 2021;33:15205-15228. [DOI: 10.1007/s00521-021-06143-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Shi Q, Lin Y, Fonseca VA, Shi L. Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2021;9:e002396. [PMID: 34675042 DOI: 10.1136/bmjdrc-2021-002396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Pashchenko Y, Clausing DH, Ablah E, Okut H, Elhomsy GC. Glycemic Control and Awareness of Insulin Therapy. Kans J Med 2021;14:249-52. [PMID: 34671440 DOI: 10.17161/kjm.vol14.15298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Heo CE, Kim M, Son MK, Hyun DG, Heo SW, Kim HI. Ion Mobility Mass Spectrometry Analysis of Oxygen Affinity-Associated Structural Changes in Hemoglobin. J Am Soc Mass Spectrom 2021;32:2528-35. [PMID: 34463503 DOI: 10.1021/jasms.1c00161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Niwaha AJ, Rodgers LR, Greiner R, Balungi PA, Mwebaze R, McDonald TJ, Hattersley AT, Shields BM, Nyirenda MJ, Jones AG. HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study. BMJ Open Diabetes Res Care 2021;9:e002350. [PMID: 34535465 DOI: 10.1136/bmjdrc-2021-002350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Cheng AYY, Feig DS, Ho J, Siemens R; Diabetes Canada Clinical Practice Guidelines Expert Working Group., Diabetes Canada Clinical Practice Guidelines Steering Committee. Blood Glucose Monitoring in Adults and Children with Diabetes: Update 2021. Can J Diabetes 2021;45:580-7. [PMID: 34511234 DOI: 10.1016/j.jcjd.2021.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Huang JH, Lin YK, Lee TW, Liu HW, Chien YM, Hsueh YC, Lee TI, Chen YJ. Correlation between short- and mid-term hemoglobin A1c and glycemic control determined by continuous glucose monitoring. Diabetol Metab Syndr 2021;13:94. [PMID: 34488880 DOI: 10.1186/s13098-021-00714-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Saleh MHA, Dukka H, Troiano G, Ravidà A, Galli M, Qazi M, Greenwell H, Wang HL. External validation and comparison of the predictive performance of 10 different tooth-level prognostic systems. J Clin Periodontol 2021;48:1421-9. [PMID: 34472120 DOI: 10.1111/jcpe.13542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Islam MS, Qaraqe MK, Belhaouari S, Petrovski G. Long Term HbA1c Prediction Using Multi-Stage CGM Data Analysis. IEEE Sensors J 2021;21:15237-15247. [DOI: 10.1109/jsen.2021.3073974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT; Omnipod 5 Research Group. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care 2021;44:1630-40. [PMID: 34099518 DOI: 10.2337/dc21-0172] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 32.0] [Reference Citation Analysis]
41 Suwattipong M, Thuramonwong T, Tantipoj C, Fuangtharnthip P, Thanakun S, Khovidhunkit W, Khovidhunkit SP. Comparison of Point-of-Care Testing and Hospital-Based Methods in Screening for Potential Type 2 Diabetes Mellitus and Abnormal Glucose Regulation in a Dental Setting. Int J Environ Res Public Health 2021;18:6459. [PMID: 34203697 DOI: 10.3390/ijerph18126459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Argun D, Argun F, Borku Uysal B. Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels. Ir J Med Sci 2021. [PMID: 34109528 DOI: 10.1007/s11845-021-02674-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Cichosz SL, Xylander AAP. A Conditional Generative Adversarial Network for Synthesis of Continuous Glucose Monitoring Signals. J Diabetes Sci Technol 2021;:19322968211014255. [PMID: 34056935 DOI: 10.1177/19322968211014255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Saleh MHA, Dukka H, Troiano G, Ravidà A, Qazi M, Wang HL, Greenwell H. Long term comparison of the prognostic performance of PerioRisk, periodontal risk assessment, periodontal risk calculator, and staging and grading systems. J Periodontol 2021. [PMID: 33914347 DOI: 10.1002/JPER.20-0662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Singha A, Bhattacharjee R, Dalal BS, Biswas D, Choudhuri S, Chowdhury S. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study. J Pediatr Endocrinol Metab 2021;34:503-8. [PMID: 33662195 DOI: 10.1515/jpem-2020-0556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
46 Friedman SM, Barnett CH, Franki R, Pollock B, Garver B, Barnett TD. Jumpstarting Health With a 15-Day Whole-Food Plant-Based Program. American Journal of Lifestyle Medicine. [DOI: 10.1177/15598276211006349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Katipoglu B, Comoglu M, Ates I, Yilmaz N, Berker D. May C-peptide index be a new marker to predict proteinuria in anemic patients with type 2 diabetes mellitus? Endocr Regul 2020;54:1-5. [PMID: 32597149 DOI: 10.2478/enr-2020-0001] [Reference Citation Analysis]
48 Chrzanowski J, Michalak A, Łosiewicz A, Kuśmierczyk H, Mianowska B, Szadkowska A, Fendler W. Improved Estimation of Glycated Hemoglobin from Continuous Glucose Monitoring and Past Glycated Hemoglobin Data. Diabetes Technology & Therapeutics 2021;23:293-305. [DOI: 10.1089/dia.2020.0433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Zarean E, Lattanzi S, Looha MA, Napoli MD, Chou SH, Jafarli A, Torbey M, Divani AA. Glycemic Gap Predicts in-Hospital Mortality in Diabetic Patients with Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis 2021;30:105669. [PMID: 33636475 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105669] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
50 Morajkar A S, Sharma Bha B, Kharat Kir R. Antihyperglycemic Efficacy of Pongamia pinnata (L.) Pierre Against Alloxan Induced Diabetic Rats and its Correlation with Phytochemical Screening. J of Applied Sciences 2021;21:51-61. [DOI: 10.3923/jas.2021.51.61] [Reference Citation Analysis]
51 Nagayama D, Watanabe Y, Yamaguchi T, Saiki A, Shirai K, Tatsuno I. High hemoglobin glycation index is associated with increased systemic arterial stiffness independent of hyperglycemia in real-world Japanese population: A cross-sectional study. Diab Vasc Dis Res 2020;17:1479164120958625. [PMID: 32985267 DOI: 10.1177/1479164120958625] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
52 Tenekecioglu E, Topal D, Mutluer F, Aydin O, Cakir H, Kanat S, Aslan B, Er F, Uslu A, Bozkaya V, Keskin M, Karsi R, Yilmaz M, Aksakal E, Demir M. The relationship between hemoglobin A1c levels and thrombus load in patients with type 2 diabetes mellitus and non-ST-segment elevation myocardial infarction. J Res Med Sci 2021;26:118. [DOI: 10.4103/jrms.jrms_997_18] [Reference Citation Analysis]
53 Herane-Vives A, Espinoza S, Sandoval R, Ortega L, Alameda L, Young AH, Arnone D, Hayes A, Benöhr J. A Novel Earwax Method to Measure Acute and Chronic Glucose Levels. Diagnostics (Basel) 2020;10:E1069. [PMID: 33321856 DOI: 10.3390/diagnostics10121069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
54 Islam MS, Qaraqe MK, Belhaouari SB. Early Prediction of Hemoglobin Alc: A novel Framework for better Diabetes Management. 2020 IEEE Symposium Series on Computational Intelligence (SSCI) 2020. [DOI: 10.1109/ssci47803.2020.9308539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Kumar S, Anand A, Nagarathna R, Kaur N, Sivapuram MS, Pannu V, Pal DK, Malik N, Singh AK, Nagendra HR. Prevalence of prediabetes, and diabetes in Chandigarh and Panchkula region based on glycated haemoglobin and Indian diabetes risk score. Endocrinol Diabetes Metab 2021;4:e00162. [PMID: 33532605 DOI: 10.1002/edm2.162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Arakawa S, Suzuki R, Kurosaka D, Ikeda R, Hayashi H, Kayama T, Ohno RI, Nagai R, Marumo K, Saito M. Mass spectrometric quantitation of AGEs and enzymatic crosslinks in human cancellous bone. Sci Rep 2020;10:18774. [PMID: 33139851 DOI: 10.1038/s41598-020-75923-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
57 Khondaker MTI, Khan JY, Refaee MA, Hajj NE, Rahman MS, Alam T. Obesity in Qatar: A Case-Control Study on the Identification of Associated Risk Factors. Diagnostics (Basel) 2020;10:E883. [PMID: 33138081 DOI: 10.3390/diagnostics10110883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
58 Khan ZA, Park S. An Electrochemical Chip to Monitor In Vitro Glycation of Proteins and Screening of Antiglycation Potential of Drugs. Pharmaceutics 2020;12:E1011. [PMID: 33113943 DOI: 10.3390/pharmaceutics12111011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Blitstein JL, Lazar D, Gregory K, McLoughlin C, Rosul L, Rains C, Hellman T, Leruth C, Mejia J. Foods for Health: An Integrated Social Medical Approach to Food Insecurity Among Patients With Diabetes. Am J Health Promot 2021;35:369-76. [PMID: 33043687 DOI: 10.1177/0890117120964144] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
60 Mahgoob MH, Moussa MM. Glycated albumin versus HbA1c as indicators of glycemic control in type I diabetic children with iron deficiency anemia. Clin Pediatr Endocrinol 2020;29:151-7. [PMID: 33088014 DOI: 10.1297/cpe.29.151] [Reference Citation Analysis]
61 Hu Y, Shen Y, Yan R, Li F, Ding B, Wang H, Su X, Ma J. Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population. Diabetes Ther 2020;11:2019-27. [PMID: 32696267 DOI: 10.1007/s13300-020-00879-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
62 Choo M, Hoy GE, Dugan SP, McEwen LN, Gunaratnam N, Wyckoff J, Jeevaraaj T, Saththiyaseelan A, Ganeikabahu B, Katulanda P, Balis U, Herman WH, Saha AK. Imputing HbA1c from capillary blood glucose levels in patients with type 2 diabetes in Sri Lanka: a cross-sectional study. BMJ Open 2020;10:e038148. [PMID: 32690534 DOI: 10.1136/bmjopen-2020-038148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
63 Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med 2020;9:E2207. [PMID: 32668564 DOI: 10.3390/jcm9072207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
64 Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. J Clin Med 2020;9:E2207. [PMID: 32668564 DOI: 10.3390/jcm9072207] [Reference Citation Analysis]
65 Tucker LA. Limited Agreement between Classifications of Diabetes and Prediabetes Resulting from the OGTT, Hemoglobin A1c, and Fasting Glucose Tests in 7412 U.S. Adults. JCM 2020;9:2207. [DOI: 10.3390/jcm9072207] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Moon J, Kim JY, Yoo S, Koh G. Fasting and Postprandial Hyperglycemia: Their Predictors and Contributions to Overall Hyperglycemia in Korean Patients with Type 2 Diabetes. Endocrinol Metab (Seoul) 2020;35:290-7. [PMID: 32615713 DOI: 10.3803/EnM.2020.35.2.290] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
67 Jang HN, Yang YS, Lee SO, Oh TJ, Koo BK, Jung HS. Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes. Endocrinol Metab (Seoul) 2019;34:382-9. [PMID: 31884738 DOI: 10.3803/EnM.2019.34.4.382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
68 Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, Ceriello A, Rhee M, Phillips LS, Chung S, Cravalho C, Jagannathan R, Monnier L, Colette C, Owens D, Bianchi C, Del Prato S, Monteiro MP, Neves JS, Medina JL, Macedo MP, Ribeiro RT, Filipe Raposo J, Dorcely B, Ibrahim N, Buysschaert M. Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract 2020;165:108233. [PMID: 32497744 DOI: 10.1016/j.diabres.2020.108233] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 22.3] [Reference Citation Analysis]
69 Hamdan MA, Gomez R, Chalew SA. Mean blood glucose-independent HbA1c racial disparity and iron status in youth with Type 1 DM. Pediatr Diabetes 2020;21:615-20. [PMID: 32134541 DOI: 10.1111/pedi.13002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
70 Zhang Y, Dai J, Han X, Zhao Y, Zhang H, Liu X, Li W, Ling H, Zhou X, Ying C. Glycemic variability indices determined by self-monitoring of blood glucose are associated with β-cell function in Chinese patients with type 2 diabetes. Diabetes Res Clin Pract 2020;164:108152. [PMID: 32360707 DOI: 10.1016/j.diabres.2020.108152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
71 Kim EJ, Han K. Factors related to self‐care behaviours among patients with diabetic foot ulcers. J Clin Nurs 2020;29:1712-22. [DOI: 10.1111/jocn.15215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
72 Tyagi K. I rely more on self-monitoring of blood glucose than HbA1c to assess diabetes control. Do you? Diabetes Metab Syndr 2020;14:173-4. [PMID: 32142997 DOI: 10.1016/j.dsx.2020.02.009] [Reference Citation Analysis]
73 Charbonnel B. What a psychiatrist needs to know about diabetes. Eur psychiatr 2005;20:S330-4. [DOI: 10.1016/s0924-9338(05)80186-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
74 Ren Q, Lv X, Yang L, Yue J, Luo Y, Zhou L, Meng S, Yang S, Puchi B, Zhou X, Ji L. Erythrocytosis and Performance of HbA1c in Detecting Diabetes on an Oxygen-Deficient Plateau: A Population-based Study. J Clin Endocrinol Metab 2020;105:dgaa001. [PMID: 31904080 DOI: 10.1210/clinem/dgaa001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Chu H, Ma Y, Huang Z. A pilot study: effect of erythrocyte lifespan determined by a modified carbon monoxide breath test on glycosylated hemoglobin interpretation. J Breath Res 2020;14:027101. [DOI: 10.1088/1752-7163/ab75f8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
76 Lum ZK, Khoo ZR, Toh WYS, Kamaldeen SAK, Shakoor A, Tsou KYK, Chew DEK, Dalan R, Kwek SC, Othman N, Lian JX, Bte Sunari RN, Lee JY. Efficacy and Safety of Use of the Fasting Algorithm for Singaporeans With Type 2 Diabetes (FAST) During Ramadan: A Prospective, Multicenter, Randomized Controlled Trial. Ann Fam Med 2020;18:139-47. [PMID: 32152018 DOI: 10.1370/afm.2500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zendjabil M. Glycated albumin. Clinica Chimica Acta 2020;502:240-4. [DOI: 10.1016/j.cca.2019.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
78 Fangel MV, Nielsen PB, Kristensen JK, Larsen TB, Overvad TF, Lip GYH, Jensen MB. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study. Circ Arrhythm Electrophysiol 2019;12:e007030. [PMID: 30995869 DOI: 10.1161/CIRCEP.118.007030] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
79 Neth BJ, Graff-Radford J, Mielke MM, Przybelski SA, Lesnick TG, Schwarz CG, Reid RI, Senjem ML, Lowe VJ, Machulda MM, Petersen RC, Jack CR Jr, Knopman DS, Vemuri P. Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging. Front Aging Neurosci 2019;11:355. [PMID: 31998113 DOI: 10.3389/fnagi.2019.00355] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
80 Rhee SY. Letter: Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes (Endocrinol Metab 2019; 34:382-9, Han Na Jang et al.). Endocrinol Metab 2020;35:192. [DOI: 10.3803/enm.2020.35.1.192] [Reference Citation Analysis]
81 Ye L, Gu W, Chen Y, Li X, Shi J, Lv A, Hu J, Zhang R, Liu R, Hong J, Wang J, Zhang Y. The impact of shift work on glycemic characteristics assessed by CGM and its association with metabolic indices in non-diabetic subjects. Acta Diabetol 2020;57:53-61. [PMID: 31240398 DOI: 10.1007/s00592-019-01372-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
82 Mach JC, Barone H, Boni C, Jimenez H, Tinglin M. Evaluating the impact of an international short-term medical mission through diabetic glycemic control. J Public Health (Oxf) 2019;41:815-20. [PMID: 30388245 DOI: 10.1093/pubmed/fdy182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Sriwimol W, Choosongsang P, Choosongsang P, Treerut P, Muenniam B, Makkong P, Pocathikorn A. Strong correlation and high comparability of capillary electrophoresis and three different methods for HbA1c measurement in a population without hemoglobinopathy. Scand J Clin Lab Invest 2020;80:139-50. [PMID: 31841038 DOI: 10.1080/00365513.2019.1703213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 El-Makaky Y, Shalaby HK. The effects of non-surgical periodontal therapy on glycemic control in diabetic patients: A randomized controlled trial. Oral Dis 2020;26:822-9. [PMID: 31834660 DOI: 10.1111/odi.13256] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
85 Ding Y, Gao K, Liu Y, Mao G, Chen K, Qiu X, Zhao T, Yang L, Feng W, Wu X. Transcriptome analysis revealed the mechanism of the metabolic toxicity and susceptibility of di-(2-ethylhexyl)phthalate on adolescent male ICR mice with type 2 diabetes mellitus. Arch Toxicol 2019;93:3183-206. [DOI: 10.1007/s00204-019-02590-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
86 McKay TB, Priyadarsini S, Karamichos D. Mechanisms of Collagen Crosslinking in Diabetes and Keratoconus. Cells 2019;8:E1239. [PMID: 31614631 DOI: 10.3390/cells8101239] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
87 Fujii M, Murakami Y, Karasawa Y, Sumitomo Y, Fujita S, Koyama M, Uda S, Kubota H, Inoue H, Konishi K, Oba S, Ishii S, Kuroda S. Logical design of oral glucose ingestion pattern minimizing blood glucose in humans. NPJ Syst Biol Appl 2019;5:31. [PMID: 31508240 DOI: 10.1038/s41540-019-0108-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
88 Gauci ML, Boudou P, Squara PA, Delyon J, Allayous C, Mourah S, Resche-Rigon M, Lebbé C, Baroudjian B, Gautier JF; PATIO group. Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients. Melanoma Res 2019;29:328-32. [PMID: 30817442 DOI: 10.1097/CMR.0000000000000585] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Ahola AJ, Forsblom C, Harjutsalo V, Groop PH; FinnDiane Study Group. Dietary carbohydrate intake and cardio-metabolic risk factors in type 1 diabetes. Diabetes Res Clin Pract 2019;155:107818. [PMID: 31425769 DOI: 10.1016/j.diabres.2019.107818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
90 Soliman G. Serum/Urine Zn Level of Egyptian Type II Diabetic Patients and Its relation with Glycemic Control (HbA1c). J Biol Med 2019;3:044-047. [DOI: 10.17352/jbm.000014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
91 Owolabi EO, Goon DT. The use of text messaging for improving adherence to anti-diabetic regimen and glycaemic control in low-resource settings of South Africa: A study protocol for a randomised controlled trial. Contemp Clin Trials Commun 2019;15:100418. [PMID: 31372574 DOI: 10.1016/j.conctc.2019.100418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
92 Xiang J, Lv Q, Yi F, Song Y, Le L, Jiang B, Xu L, Xiao P. Dietary Supplementation of Vine Tea Ameliorates Glucose and Lipid Metabolic Disorder via Akt Signaling Pathway in Diabetic Rats. Molecules 2019;24:E1866. [PMID: 31096578 DOI: 10.3390/molecules24101866] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
93 Bellia C, Cosma C, Lo Sasso B, Bivona G, Agnello L, Zaninotto M, Ciaccio M. Glycated albumin as a glycaemic marker in patients with advanced chronic kidney disease and anaemia: a preliminary report. Scand J Clin Lab Invest 2019;79:293-7. [PMID: 31070491 DOI: 10.1080/00365513.2019.1613673] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
94 Lim PC, Lim SL, Khaw CH, Lim YL, Hassali MA, Chong CP. Drowsiness associated with a generic fixed‐dose glibenclamide/metformin combination tablet. J Pharm Pract Res 2019;49:171-175. [DOI: 10.1002/jppr.1451] [Reference Citation Analysis]
95 Maeda Y, Nakamura N, Tsujimoto T, Sugano N. Higher blood glucose and larger fluctuations detected postoperatively using continuous glucose monitoring: a preliminary study following total knee or hip arthroplasty. J Exp Orthop 2019;6:15. [PMID: 30937670 DOI: 10.1186/s40634-019-0181-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Jafarnejad S, Mahboobi S, McFarland LV, Taghizadeh M, Rahimi F. Meta-Analysis: Effects of Zinc Supplementation Alone or with Multi-Nutrients, on Glucose Control and Lipid Levels in Patients with Type 2 Diabetes. Prev Nutr Food Sci 2019;24:8-23. [PMID: 31008092 DOI: 10.3746/pnf.2019.24.1.8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
97 Flohr BAL, Maifrino LB, da Costa Aguiar Alves B, da Veiga GL, de Sousa Gehrke F, Fonseca FLA. Use of the turbidimetric method for determining hemoglobin (A1C) in diabetic and nondiabetic dogs. Comp Clin Pathol 2019;28:1087-94. [DOI: 10.1007/s00580-019-02932-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci 2019;19:1602-6. [PMID: 31148989 DOI: 10.4314/ahs.v19i1.35] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
99 Sara JD, Taher R, Kolluri N, Vella A, Lerman LO, Lerman A. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease. Cardiovasc Diabetol 2019;18:22. [PMID: 30819191 DOI: 10.1186/s12933-019-0833-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
100 Chakrabarty A, Gregory JM, Moore LM, Williams PE, Farmer B, Cherrington AD, Lord P, Shelton B, Cohen D, Zisser HC, Doyle FJ 3rd, Dassau E. A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance. J Process Control 2019;76:62-73. [PMID: 31178632 DOI: 10.1016/j.jprocont.2019.01.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
101 Masuch A, Friedrich N, Roth J, Nauck M, Müller UA, Petersmann A. Preventing misdiagnosis of diabetes in the elderly: age-dependent HbA1c reference intervals derived from two population-based study cohorts. BMC Endocr Disord 2019;19:20. [PMID: 30755204 DOI: 10.1186/s12902-019-0338-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
102 Walicka M, Jozwiak J, Rzeszotarski J, Zonenberg A, Masierek M, Bijos P, Franek E. Diagnostic Accuracy of Glycated Haemoglobin and Average Glucose Values in Type 2 Diabetes Mellitus Treated with Premixed Insulin. Diabetes Ther 2019;10:587-96. [PMID: 30734901 DOI: 10.1007/s13300-019-0570-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Almeida PHRF, Silva TBC, de Assis Acurcio F, Guerra Júnior AA, Araújo VE, Diniz LM, Godman B, Almeida AM, Alvares J. Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications. Patient 2018;11:377-89. [PMID: 29322308 DOI: 10.1007/s40271-017-0291-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
104 Vigersky RA, Mcmahon C. The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. Diabetes Technology & Therapeutics 2019;21:81-5. [DOI: 10.1089/dia.2018.0310] [Cited by in Crossref: 193] [Cited by in F6Publishing: 202] [Article Influence: 48.3] [Reference Citation Analysis]
105 Eltonsy S, Dufour Doiron M, Simard P, Jose C, Sénéchal M, Bouchard DR, LeBlanc R, Bélanger M. Effects of the combination of metformin and exercise on glycated hemoglobin, functional capacity, lipid profile, quality of life, and body weight. J Int Med Res 2019;47:1131-45. [PMID: 30614342 DOI: 10.1177/0300060518817164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
106 Oyapero A, Adeniyi A, Sofola O, Ogbera A. Effect of glycemic control on periodontal disease and caries experience in diabetic patients: A pilot study. J Interdiscip Dentistry 2019;9:99. [DOI: 10.4103/jid.jid_67_18] [Reference Citation Analysis]
107 Amini P, Moharamzadeh S. Comment on 'Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial'. Diabetologia 2019;62:202-3. [PMID: 30402775 DOI: 10.1007/s00125-018-4765-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
108 Azmon M, Gayus N, Michal H, Olmer L, Cukierman-Yaffe T. The Association between Glucose Control and Functional Indices in Older People with Diabetes. Int J Endocrinol 2018;2018:1053815. [PMID: 30675156 DOI: 10.1155/2018/1053815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Freckmann G, Mende J. Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments. LaboratoriumsMedizin 2018;42:225-33. [DOI: 10.1515/labmed-2018-0119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
110 Finan E, Joseph J. Glycosylated haemoglobin: a false sense of security. BMJ Case Rep 2018;11:e227668. [PMID: 30567208 DOI: 10.1136/bcr-2018-227668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
111 Asha Madhavan A, Juneja S, Sen P, Ghosh Moulick R, Bhattacharya J. Gold Nanoparticle-Based Detection of Low Molecular Weight AGEs from In Vitro Glycated Haemoglobin A0 Samples. Nanoscale Res Lett 2018;13:390. [PMID: 30511188 DOI: 10.1186/s11671-018-2812-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
112 Asle Mohammadi Zadeh M, Kargarfard M, Marandi SM, Habibi A. Diets along with interval training regimes improves inflammatory & anti-inflammatory condition in obesity with type 2 diabetes subjects. J Diabetes Metab Disord 2018;17:253-67. [PMID: 30918861 DOI: 10.1007/s40200-018-0368-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
113 Sodi R, McKay K, Dampetla S, Pappachan JM. Monitoring glycaemic control in patients with diabetes mellitus. BMJ 2018;363:k4723. [PMID: 30459149 DOI: 10.1136/bmj.k4723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
114 Chalew S, Hamdan M. Racial disparity in HbA1c persists when fructosamine is used as a surrogate for mean blood glucose in youth with type 1 diabetes. Pediatr Diabetes 2018;19:1243-8. [PMID: 29808574 DOI: 10.1111/pedi.12696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
115 Choi DW, Jeon J, Lee SA, Han KT, Park EC, Jang SI. Association between Smoking Behavior Patterns and Glycated Hemoglobin Levels in a General Population. Int J Environ Res Public Health 2018;15:E2260. [PMID: 30332732 DOI: 10.3390/ijerph15102260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
116 Misra A, Bloomgarden ZT. Discordance between HbA1c and glycemia: HbA1c与血糖之间的不一致现象. Journal of Diabetes 2018;10:908-10. [DOI: 10.1111/1753-0407.12843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
117 Cianciosi D, Forbes-Hernández TY, Afrin S, Gasparrini M, Reboredo-Rodriguez P, Manna PP, Zhang J, Bravo Lamas L, Martínez Flórez S, Agudo Toyos P, Quiles JL, Giampieri F, Battino M. Phenolic Compounds in Honey and Their Associated Health Benefits: A Review. Molecules 2018;23:E2322. [PMID: 30208664 DOI: 10.3390/molecules23092322] [Cited by in Crossref: 228] [Cited by in F6Publishing: 238] [Article Influence: 45.6] [Reference Citation Analysis]
118 Sabharwal A, Gomes-filho IS, Stellrecht E, Scannapieco F. Role of periodontal therapy in management of common complex systemic diseases and conditions: An update. Periodontol 2000 2018;78:212-26. [DOI: 10.1111/prd.12226] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
119 Borg R, Persson F, Siersma V, Lind B, de Fine Olivarius N, Andersen CL. Interpretation of HbA 1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database. Diabet Med 2018;35:1700-6. [DOI: 10.1111/dme.13776] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
120 Karakas SE, Surampudi P. New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men. Adv Clin Chem 2018;86:71-125. [PMID: 30144842 DOI: 10.1016/bs.acc.2018.06.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
121 Quintero AJ, Chaparro A, Quirynen M, Ramirez V, Prieto D, Morales H, Prada P, Hernández M, Sanz A. Effect of two periodontal treatment modalities in patients with uncontrolled type 2 diabetes mellitus: A randomized clinical trial. J Clin Periodontol 2018;45:1098-106. [PMID: 30024030 DOI: 10.1111/jcpe.12991] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
122 Miyamoto T, Iwakura T, Matsuoka N, Iwamoto M, Takenaka M, Akamatsu Y, Moritani T. Impact of prolonged neuromuscular electrical stimulation on metabolic profile and cognition-related blood parameters in type 2 diabetes: A randomized controlled cross-over trial. Diabetes Research and Clinical Practice 2018;142:37-45. [DOI: 10.1016/j.diabres.2018.05.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
123 Chan CL, Hope E, Thurston J, Vigers T, Pyle L, Zeitler PS, Nadeau KJ. Hemoglobin A(1c) Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis. Diabetes Care 2018;41:1406-13. [PMID: 29674323 DOI: 10.2337/dc17-2419] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
124 Lennerz BS, Barton A, Bernstein RK, Dikeman RD, Diulus C, Hallberg S, Rhodes ET, Ebbeling CB, Westman EC, Yancy WS Jr, Ludwig DS. Management of Type 1 Diabetes With a Very Low-Carbohydrate Diet. Pediatrics 2018;141. [PMID: 29735574 DOI: 10.1542/peds.2017-3349] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 14.4] [Reference Citation Analysis]
125 Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. J Endocr Soc 2018;2:687-709. [PMID: 29951596 DOI: 10.1210/js.2017-00472] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 11.2] [Reference Citation Analysis]
126 Terauchi Y, Yamada Y, Watada H, Nakatsuka Y, Shiosakai K, Washio T, Taguchi T. Efficacy and safety of the G protein-coupled receptor 119 agonist DS-8500a in Japanese type 2 diabetes mellitus patients with inadequate glycemic control on sitagliptin: A phase 2 randomized placebo-controlled study. J Diabetes Investig. 2018;9:1333-1341. [PMID: 29607623 DOI: 10.1111/jdi.12846] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
127 Sayed A, Alyafei F, De Sanctis V, Soliman A, Elgamal M. Translating the HbA1c assay into estimated average glucose values in children and adolescents with type 1 diabetes mellitus. Acta Biomed 2018;89:22-6. [PMID: 30049928 DOI: 10.23750/abm.v89iS4.7357] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Qian S, Zhang Y, Yuan H, Ji W, Liu Y, Zhao J, Han M, Peng W. Boronic acid functionalized fiber-optic SPR sensors for high sensitivity glycoprotein detection. Sensors and Actuators B: Chemical 2018;260:976-82. [DOI: 10.1016/j.snb.2017.12.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
129 Raghav A, Ahmad J, Noor S, Alam K, Mishra BK. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2018;12:381-5. [DOI: 10.1016/j.dsx.2018.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
130 Coelho S. Is the management of diabetes different in dialysis patients? Semin Dial 2018;31:367-76. [PMID: 29659052 DOI: 10.1111/sdi.12698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
131 Fan W, Zheng H, Wei N, Nathan DM. Estimating HbA1c from timed Self-Monitored Blood Glucose values. Diabetes Res Clin Pract 2018;141:56-61. [PMID: 29673846 DOI: 10.1016/j.diabres.2018.04.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
132 Berard LD, Siemens R, Woo V. Monitoring Glycemic Control. Canadian Journal of Diabetes 2018;42:S47-53. [DOI: 10.1016/j.jcjd.2017.10.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
133 Shi Q, Liu S, Krousel-Wood M, Shao H, Fonseca V, Shi L. Long-term outcomes associated with triple-goal achievement in patients with type 2 diabetes mellitus (T2DM). Diabetes Res Clin Pract 2018;140:45-54. [PMID: 29596940 DOI: 10.1016/j.diabres.2018.02.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
134 Kameyama M, Takeuchi S, Ishii S. Steady-state relationship between average glucose, HbA1c and RBC lifespan. J Theor Biol 2018;447:111-7. [PMID: 29559230 DOI: 10.1016/j.jtbi.2018.03.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
135 Taboza ZA, Costa KL, Silveira VR, Furlaneto FA, Montenegro R, Russell S, Dasanayake A, Rego RO. Periodontitis, edentulism and glycemic control in patients with type 2 diabetes: a cross-sectional study. BMJ Open Diabetes Res Care. 2018;6:e000453. [PMID: 29607049 DOI: 10.1136/bmjdrc-2017-000453] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
136 Kim G, Jang SY, Nam CM, Kang ES. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study. J Hepatol 2018;68:476-84. [PMID: 29107150 DOI: 10.1016/j.jhep.2017.10.018] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
137 Sarkar J, Dwivedi G, Chen Q, Sheu IE, Paich M, Chelini CM, D'Alessandro PM, Burns SP. A long-term mechanistic computational model of physiological factors driving the onset of type 2 diabetes in an individual. PLoS One 2018;13:e0192472. [PMID: 29444133 DOI: 10.1371/journal.pone.0192472] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
138 Ding L, Xu Y, Liu S, Bi Y, Xu Y. Hemoglobin A1c and diagnosis of diabetes. J Diabetes 2018;10:365-72. [PMID: 29292842 DOI: 10.1111/1753-0407.12640] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
139 Schlienger J. Le demi-siècle de l’hémoglobine glyquée. Médecine des Maladies Métaboliques 2018;12:93-96. [DOI: 10.1016/s1957-2557(18)30021-x] [Reference Citation Analysis]
140 Lu Y, Wang P, Zhou T, Lu J, Spatz ES, Nasir K, Jiang L, Krumholz HM. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States. J Am Heart Assoc 2018;7:e007462. [PMID: 29374046 DOI: 10.1161/JAHA.117.007462] [Cited by in Crossref: 73] [Cited by in F6Publishing: 82] [Article Influence: 14.6] [Reference Citation Analysis]
141 Chattopadhyay K. Glycemic Excursions in Diabetic Kidney Disease: Comparison of Three Therapeutic Arms. EMIJ 2018;6. [DOI: 10.15406/emij.2018.06.00149] [Reference Citation Analysis]
142 Praveena V, N N S. ASSOCIATION OF GLYCATED HAEMOGLOBIN WITH LIPID PROFILE IN TYPE 2 DIABETES PATIENTS. jemds 2018;7:445-448. [DOI: 10.14260/jemds/2018/99] [Reference Citation Analysis]
143 Mauri-obradors E, Merlos A, Estrugo-devesa A, Jané-salas E, López-lópez J, Viñas M. Benefits of non-surgical periodontal treatment in patients with type 2 diabetes mellitus and chronic periodontitis: A randomized controlled trial. J Clin Periodontol 2018;45:345-53. [DOI: 10.1111/jcpe.12858] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
144 Schäffler A, Bollheimer C, Büttner R, Girlich C, Aslanidis C, Dietmaier W, Bala M, Guralnik V, Karrasch T, Schneider S. Kohlenhydratstoffwechsel. Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel 2018. [DOI: 10.1007/978-3-662-55914-7_2] [Reference Citation Analysis]
145 Zemva J. Fall 8: Therapie – 25 Jahre, ♀, DM Typ 1. Diabetes-Therapie – informiert entscheiden 2018. [DOI: 10.1007/978-3-662-55972-7_8] [Reference Citation Analysis]
146 Bismuth E, Coutant R. Autosurveillance glycémique : objectifs de glycémie, objectifs d’HbA1c. Diabétologie de L'enfant 2018. [DOI: 10.1016/b978-2-294-74942-1.00013-6] [Reference Citation Analysis]
147 Belay E, Abera A, Mehari A, Gebremeskel G, Endrias A, Endris K. Achievements of Diabetes Goals and Their Determinants in Type 2 Diabetic Patients Attending Outpatient Diabetic Clinic in Northern Ethiopia. Int J Chronic Dis 2017;2017:5713187. [PMID: 29464189 DOI: 10.1155/2017/5713187] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
148 Schade DS. The Timing of Meal Insulin Administration. Endocrine Practice 2017;23:1482-4. [DOI: 10.4158/ep-2017-0073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Osborn CY, van Ginkel JR, Marrero DG, Rodbard D, Huddleston B, Dachis J. One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care. JMIR Mhealth Uhealth 2017;5:e179. [PMID: 29187344 DOI: 10.2196/mhealth.8781] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
150 Spasov AA, Babkov DA, Sysoeva VA, Litvinov RA, Shamshina DD, Ulomsky EN, Savateev KV, Fedotov VV, Slepukhin PA, Chupakhin ON, Charushin VN, Rusinov VL. 6-Nitroazolo[1,5- a ]pyrimidin-7(4 H )-ones as Antidiabetic Agents: 6-Nitroazolo[1,5- a ]pyrimidin-7(4 H )-ones as Antidiabetic Agents. Arch Pharm Chem Life Sci 2017;350:1700226. [DOI: 10.1002/ardp.201700226] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
151 Mangrola D, Cox C, Furman AS, Krishnan S, Karakas SE. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES. Endocr Pract 2018;24:47-52. [PMID: 29144814 DOI: 10.4158/EP-2017-0032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
152 Freckmann G. HbA1c-POC-Systeme zur Therapiekontrolle und Diagnostik des Diabetes: Ausreichende Qualität und Qualitätskontrolle? LaboratoriumsMedizin 2017;41. [DOI: 10.1515/labmed-2017-0089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 . Patient Selection for Implant Therapy: Oral Systemic Health, Medical History, and Risk Assessment. Peri-Implant Therapy for the Dental Hygienist 2017. [DOI: 10.1002/9781119421498.ch2] [Reference Citation Analysis]
154 Han J, Chen X, Wang Y, Fei Y, Zhou F, Zhang Y, Liu L, Si P, Fu J. Xenopus GLP-1-inspired discovery of novel GLP-1 receptor agonists as long-acting hypoglycemic and insulinotropic agents with significant therapeutic potential. Biochemical Pharmacology 2017;142:155-67. [DOI: 10.1016/j.bcp.2017.06.132] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
155 Masuda K, Noguchi S, Ono M, Ochi T, Munekage K, Okamoto N, Suganuma N, Saibara T. High fasting insulin concentrations may be a pivotal predictor for the severity of hepatic fibrosis beyond the glycemic status in non-alcoholic fatty liver disease patients before development of diabetes mellitus. Hepatol Res 2017;47:983-90. [PMID: 27794176 DOI: 10.1111/hepr.12832] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
156 Osborn CY, van Ginkel JR, Rodbard D, Heyman M, Marrero DG, Huddleston B, Dachis J. One Drop | Mobile: An Evaluation of Hemoglobin A1c Improvement Linked to App Engagement. JMIR Diabetes 2017;2:e21. [PMID: 30291059 DOI: 10.2196/diabetes.8039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
157 Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The Fallacy of Average: How Using HbA(1c) Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care 2017;40:994-9. [PMID: 28733374 DOI: 10.2337/dc17-0636] [Cited by in Crossref: 254] [Cited by in F6Publishing: 248] [Article Influence: 42.3] [Reference Citation Analysis]
158 Yoo KH, Shin DW, Cho MH, Kim SH, Bahk HJ, Kim SH, Jeong SM, Yun JM, Park JH, Kim H, Cho B. Regional variations in frequency of glycosylated hemoglobin (HbA1c) monitoring in Korea: A multilevel analysis of nationwide data. Diabetes Res Clin Pract 2017;131:61-9. [PMID: 28689084 DOI: 10.1016/j.diabres.2017.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
159 Karakas SE. New biomarkers for diagnosis and management of polycystic ovary syndrome. Clin Chim Acta 2017;471:248-53. [PMID: 28624501 DOI: 10.1016/j.cca.2017.06.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
160 Walsh EI, Jacka FN, Butterworth P, Anstey KJ, Cherbuin N. The association between Western and Prudent dietary patterns and fasting blood glucose levels in type 2 diabetes and normal glucose metabolism in older Australian adults. Heliyon 2017;3:e00315. [PMID: 28626807 DOI: 10.1016/j.heliyon.2017.e00315] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
161 Ahn CH, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Ha J, Sherman AS, Lim S. Hemoglobin Glycation Index Is Associated With Cardiovascular Diseases in People With Impaired Glucose Metabolism. J Clin Endocrinol Metab 2017;102:2905-13. [PMID: 28541544 DOI: 10.1210/jc.2017-00191] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 7.5] [Reference Citation Analysis]
162 Lee S, Park H, Kim K, Sohn Y, Jang S, Park Y. Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus. Sci Rep 2017;7:1039. [PMID: 28432323 DOI: 10.1038/s41598-017-01036-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 9.7] [Reference Citation Analysis]
163 Sarkar S, Meshram A. HBA1C AND LIPID PROFILE LEVELS IN THE KNOWN TYPE 2 DIABETIC GROUP IN THE RURAL REGION OF VIDARBHA, MAHARASHTRA, INDIA. jebmh 2017;4:1915-1920. [DOI: 10.18410/jebmh/2017/374] [Reference Citation Analysis]
164 Claussen A, Møller JB, Kristensen NR, Klim S, Kjellsson MC, Ingwersen SH, Karlsson MO. Impact of demographics and disease progression on the relationship between glucose and HbA1c. Eur J Pharm Sci 2017;104:417-23. [PMID: 28412484 DOI: 10.1016/j.ejps.2017.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
165 Law GR, Gilthorpe MS, Secher AL, Temple R, Bilous R, Mathiesen ER, Murphy HR, Scott EM. Translating HbA(1c) measurements into estimated average glucose values in pregnant women with diabetes. Diabetologia 2017;60:618-24. [PMID: 28105519 DOI: 10.1007/s00125-017-4205-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 7.2] [Reference Citation Analysis]
166 Duran-valdez E, Burge MR, Broderick P, Shey L, Valentine V, Schrader RM, Schade DS. Insulin Timing: A Patient-Centered Approach To Improve Control In Type 1 Diabetes. Endocrine Practice 2017;23:471-8. [DOI: 10.4158/ep161265.or] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
167 Tessari P, Lante A. A Multifunctional Bread Rich in Beta Glucans and Low in Starch Improves Metabolic Control in Type 2 Diabetes: A Controlled Trial. Nutrients 2017;9:E297. [PMID: 28304350 DOI: 10.3390/nu9030297] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
168 Sengani M, V DR. Identification of potential antioxidant indices by biogenic gold nanoparticles in hyperglycemic Wistar rats. Environmental Toxicology and Pharmacology 2017;50:11-9. [DOI: 10.1016/j.etap.2017.01.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
169 Maleska A, Hirtz C, Casteleyn E, Villard O, Ducos J, Avignon A, Sultan A, Lehmann S. Comparison of HbA1c detection in whole blood and dried blood spots using an automated ion-exchange HPLC system. Bioanalysis 2017;9:427-34. [PMID: 28220711 DOI: 10.4155/bio-2016-0278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
170 Nakamura PM, Mielke GI, Horta BL, Assunção MC, Gonçalves H, Menezes AMB, Barros FC, Ekelund U, Brage S, Wehrmeister FC, Oliveira IO, Hallal PC. Physical Activity Throughout Adolescence and Hba1c in Early Adulthood: Birth Cohort Study. J Phys Act Health 2017;14:375-81. [PMID: 28169566 DOI: 10.1123/jpah.2016-0245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
171 Jaramillo R, Shuck SC, Chan YS, Liu X, Bates SE, Lim PP, Tamae D, Lacoste S, O'Connor TR, Termini J. DNA Advanced Glycation End Products (DNA-AGEs) Are Elevated in Urine and Tissue in an Animal Model of Type 2 Diabetes. Chem Res Toxicol 2017;30:689-98. [PMID: 28107623 DOI: 10.1021/acs.chemrestox.6b00414] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
172 Hazell TJ, Olver TD, Kowalchuk H, McDonald MW, Dey A, Grisé KN, Noble EG, Melling CW, Lavery P, Weiler HA. Aerobic Endurance Training Does Not Protect Bone Against Poorly Controlled Type 1 Diabetes in Young Adult Rats. Calcif Tissue Int 2017;100:374-81. [PMID: 28110443 DOI: 10.1007/s00223-016-0227-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
173 Zhang D, Guo D, Yan K. A Breath Analysis System for Diabetes Screening and Blood Glucose Level Prediction. Breath Analysis for Medical Applications 2017. [DOI: 10.1007/978-981-10-4322-2_14] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
174 Mercaldo F, Nardone V, Santone A. Diabetes Mellitus Affected Patients Classification and Diagnosis through Machine Learning Techniques. Procedia Computer Science 2017;112:2519-28. [DOI: 10.1016/j.procs.2017.08.193] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 10.3] [Reference Citation Analysis]
175 Chan DML, Murphy M. Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients. J R Nav Med Serv 2017;103:39-43. [DOI: 10.1136/jrnms-103-39] [Reference Citation Analysis]
176 Torimoto K, Okada Y, Sugino S, Tanaka Y. Determinants of hemoglobin A1c level in patients with type 2 diabetes after in-hospital diabetes education: A study based on continuous glucose monitoring. J Diabetes Investig 2017;8:314-20. [PMID: 27790855 DOI: 10.1111/jdi.12589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
177 Lee S, Park H, Kim K, Sohn Y, Jang S, Park Y. Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus.. [DOI: 10.1101/087460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
178 Su Q, Liu C, Zheng H, Zhu J, Li PF, Qian L, Yang WY. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial: 中国2型糖尿病患者使用赖脯胰岛素预混25与赖脯胰岛素预混50作为胰岛素起始治疗方案的对照研究(CLASSIFY研究):开放标签的随机4期试验亚组分析. Journal of Diabetes 2017;9:575-85. [DOI: 10.1111/1753-0407.12442] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
179 Al Lenjawi B, Mohamed H, Amuna P, Zotor F, Ziki MDA. Nurse-led theory-based educational intervention improves glycemic and metabolic parameters in South Asian patients with type II diabetes: a randomized controlled trial. Diabetol Int 2017;8:95-103. [PMID: 30603312 DOI: 10.1007/s13340-016-0286-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
180 Reidpath DD, Jahan NK, Mohan D, Allotey P. Single, community-based blood glucose readings may be a viable alternative for community surveillance of HbA1c and poor glycaemic control in people with known diabetes in resource-poor settings. Glob Health Action 2016;9:31691. [PMID: 27511810 DOI: 10.3402/gha.v9.31691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
181 Luconi M, Nreu B, Samavat J, Lorubbio M, Ognibene A, Monami M, Mannucci E. Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes? Acta Diabetol 2016;53:669-72. [PMID: 26384999 DOI: 10.1007/s00592-015-0809-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
182 Nishida Y, Hara M, Sakamoto T, Shinchi K, Kawai S, Naito M, Hamajima N, Kadota A, Suzuki S, Ibusuki R, Hirata A, Yamaguchi M, Kuriyama N, Oze I, Mikami H, Kubo M, Tanaka H; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group. Influence of cigarette smoking and inflammatory gene polymorphisms on glycated hemoglobin in the Japanese general population. Prev Med Rep 2016;3:288-95. [PMID: 27419029 DOI: 10.1016/j.pmedr.2016.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
183 Koga M, Inada S, Nakao T, Kawamori R, Kasayama S. The Glycated Albumin (GA) to HbA1c Ratio Reflects Shorter-Term Glycemic Control than GA: Analysis of Patients with Fulminant Type 1 Diabetes. J Clin Lab Anal. 2017;31. [PMID: 27386821 DOI: 10.1002/jcla.22023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
184 Penttilä I, Penttilä K, Holm P, Laitinen H, Ranta P, Törrönen J, Rauramaa R. Methods, units and quality requirements for the analysis of haemoglobin A1c in diabetes mellitus. World J Methodol 2016; 6(2): 133-142 [PMID: 27376018 DOI: 10.5662/wjm.v6.i2.133] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
185 Han JA, Kim SJ, Kim G, Kim EJ, Lee SY. Factors affecting screening for diabetic complications in the community: a multilevel analysis. Epidemiol Health 2016;38:e2016017. [PMID: 27156347 DOI: 10.4178/epih.e2016017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
186 Cha S, Ko S. Association between estimated blood glucose levels and glycated hemoglobin levels. Korean J Intern Med 2016;31:457-460. [DOI: 10.3904/kjim.2016.101] [Reference Citation Analysis]
187 Nagy B, Zsólyom A, Nagyjánosi L, Merész G, Steiner T, Papp E, Dessewffy Z, Jermendy G, Winkler G, Kaló Z, Vokó Z. Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes: Cost-effectiveness of T2DM Screening. Diabetes Metab Res Rev 2016;32:710-29. [DOI: 10.1002/dmrr.2791] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
188 Marra LP, Araújo VE, Silva TB, Diniz LM, Guerra Junior AA, Acurcio FA, Godman B, Álvares J. Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis. Diabetes Ther 2016;7:241-58. [PMID: 27048292 DOI: 10.1007/s13300-016-0166-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
189 Zou X, Li Y, Cai X, Zhang S, Zhang X, Han X, Zhou X, Ji L. Decreased Glycemic Difference Between Diabetes and Nondiabetes in the Elderly Leads to the Reduced Diagnostic Accuracy of Hemoglobin A1c for Diabetes Screening in an Aged Chinese Population. Diabetes Technology & Therapeutics 2016;18:226-32. [DOI: 10.1089/dia.2015.0353] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
190 Bhaskar Biswas I, Maity C. PROSPECTIVE STUDY OF LIPID PROFILE IN DIFFERENT STAGES OF DIABETES. jemds 2016;5:1160-1164. [DOI: 10.14260/jemds/2016/270] [Reference Citation Analysis]
191 Boutayeb W, Boutayeb A, Lamlili M, Ben El Mostafa S, Zitouni N. Simulation of a computed HbA1c using a weighted average glucose. Springerplus 2016;5:226. [PMID: 27026920 DOI: 10.1186/s40064-016-1877-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
192 Cooper TT, Hess DA. The IsletCore Program: Improving the Supply of Human Islets to Satisfy the Demand for Research. See article in Endocrinology 2016;157:560-569. Endocrinology 2016;157:997-1002. [PMID: 26919514 DOI: 10.1210/en.2016-1061] [Reference Citation Analysis]
193 Kim HJ, Kim YG, Park JS, Ahn YH, Ha KH, Kim DJ. Association between blood glucose level derived using the oral glucose tolerance test and glycated hemoglobin level. Korean J Intern Med 2016;31:535-42. [PMID: 26898598 DOI: 10.3904/kjim.2015.075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
194 Spasovski S, Belazelkoska Z, Popovska M, Atanasovska-Stojanovska A, Radojkova-Nikolovska V, Muratovska I, Toseska-Spasova N, Dzipunova B, Nikolovski B. Clinical Therapeutic Effects of the Application of Doxycycline in the Treatment of Periodontal Disease. Open Access Maced J Med Sci 2016;4:152-7. [PMID: 27275351 DOI: 10.3889/oamjms.2016.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
195 Leow MK. Glycated Hemoglobin (HbA1c): Clinical Applications of a Mathematical Concept. Acta Inform Med 2016;24:233-8. [PMID: 27708483 DOI: 10.5455/aim.2016.24.233-238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
196 Bosley JR, Maurer TS, Musante CJ. Systems Pharmacology Modeling in Type 2 Diabetes Mellitus. Systems Pharmacology and Pharmacodynamics 2016. [DOI: 10.1007/978-3-319-44534-2_20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
197 Bulut A, Bulut A. Evaluation of anxiety condition among type 1 and type 2 diabetic patients. Neuropsychiatr Dis Treat 2016;12:2573-9. [PMID: 27785034 DOI: 10.2147/NDT.S105588] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
198 Retnakaran R, Zinman B. Treatment of Type 1 Diabetes Mellitus in Adults. Endocrinology: Adult and Pediatric 2016. [DOI: 10.1016/b978-0-323-18907-1.00044-5] [Reference Citation Analysis]
199 Polonsky KS, Burant CF. Type 2 Diabetes Mellitus. Williams Textbook of Endocrinology 2016. [DOI: 10.1016/b978-0-323-29738-7.00031-9] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
200 Boutayeb W, Lamlili M, Ben El Mostafa S, Zitouni N, Boutayeb A. Seeking a low value of HbA1c may be dangerous under recurrent episodes of hypoglycaemia: A short report. MNM 2015;8:213-216. [DOI: 10.3233/mnm-150045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
201 Shin SB, Kim TU, Hyun JK, Kim JY. The Prediction of Clinical Outcome Using HbA1c in Acute Ischemic Stroke of the Deep Branch of Middle Cerebral Artery. Ann Rehabil Med 2015;39:1011-7. [PMID: 26798617 DOI: 10.5535/arm.2015.39.6.1011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
202 Anand P, Arya ML, Kumar V, Jain R, Jyotirmay J. ROLE OF HBA1C AND HS - CRP IN TYPE 2 DIABETES MELLITUS WITH CARDIOVASCULAR DISEASES. jemds 2015;4:16407-16410. [DOI: 10.14260/jemds/2015/2430] [Reference Citation Analysis]
203 Rajput R, Saini O, Rajput M, Shankar V. Comparison of HbA1c and FPG as a screening tool for diagnosis of pre-diabetes and diabetes in Indian population. Int J Diabetes Dev Ctries 2015;35:559-564. [DOI: 10.1007/s13410-015-0343-y] [Reference Citation Analysis]
204 Okosun IS, Seale JP, Lyn R, Davis-Smith YM. Improving Detection of Prediabetes in Children and Adults: Using Combinations of Blood Glucose Tests. Front Public Health 2015;3:260. [PMID: 26636060 DOI: 10.3389/fpubh.2015.00260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
205 Zhang D, Yuan Q, Zabala P, Zhang F, Ngo L, Darby I. Diabetic and cardiovascular risk in patients diagnosed with periodontitis. Aust Dent J 2015;60:455-62. [DOI: 10.1111/adj.12253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
206 Zheng X, Podariu M, Matsuda R, Hage DS. Analysis of free drug fractions in human serum by ultrafast affinity extraction and two-dimensional affinity chromatography. Anal Bioanal Chem 2016;408:131-40. [PMID: 26462924 DOI: 10.1007/s00216-015-9082-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
207 Aitken-Saavedra J, Rojas-Alcayaga G, Maturana-Ramírez A, Escobar-Álvarez A, Cortes-Coloma A, Reyes-Rojas M, Viera-Sapiain V, Villablanca-Martínez C, Morales-Bozo I. Salivary gland dysfunction markers in type 2 diabetes mellitus patients. J Clin Exp Dent 2015;7:e501-5. [PMID: 26535097 DOI: 10.4317/jced.52329] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
208 Flory J, Haynes K, Leonard CE, Hennessy S. Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes. Br J Clin Pharmacol 2015;79:330-6. [PMID: 25199921 DOI: 10.1111/bcp.12506] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
209 Bloomgarden Z, Ning G. Self-monitoring of blood glucose for type 2 diabetes. Journal of Diabetes 2015;7:593-594. [DOI: 10.1111/1753-0407.12307] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
210 Valenzuela-Garcia LF, Matsuzawa Y, Sara JD, Kwon TG, Lennon RJ, Lerman LO, Ruiz-Salmeron RJ, Lerman A. Lack of correlation between the optimal glycaemic control and coronary micro vascular dysfunction in patients with diabetes mellitus: a cross sectional study. Cardiovasc Diabetol 2015;14:106. [PMID: 26268857 DOI: 10.1186/s12933-015-0269-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
211 Renard E. Does A1c Have to Change for Hypoglycemia Reduction? Diabetes Technol Ther 2015;17:527-9. [PMID: 25978209 DOI: 10.1089/dia.2015.0164] [Reference Citation Analysis]
212 Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Zhang M, Wang Y, Fonseca VA. Glycemic and Cholesterol Control Versus Single-Goal Control in US Veterans with Newly Diagnosed Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther 2015;6:339-55. [PMID: 26202185 DOI: 10.1007/s13300-015-0122-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
213 Coelho S. What is the Role of HbA1c in Diabetic Hemodialysis Patients? Semin Dial 2016;29:19-23. [PMID: 26138753 DOI: 10.1111/sdi.12408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
214 Kunstman JW, Healy JM, Araya DA, Salem RR. Effects of preoperative long-term glycemic control on operative outcomes following pancreaticoduodenectomy. The American Journal of Surgery 2015;209:1053-62. [DOI: 10.1016/j.amjsurg.2014.06.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
215 Hirata T, Higashiyama A, Kubota Y, Nishimura K, Sugiyama D, Kadota A, Nishida Y, Imano H, Nishikawa T, Miyamatsu N, Miyamoto Y, Okamura T. HOMA-IR Values are Associated With Glycemic Control in Japanese Subjects Without Diabetes or Obesity: The KOBE Study. J Epidemiol 2015;25:407-14. [PMID: 26005064 DOI: 10.2188/jea.JE20140172] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
216 Vos FE, Schollum JB, Walker RJ. Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease. NDT Plus 2011;4:368-75. [PMID: 25984197 DOI: 10.1093/ndtplus/sfr140] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
217 Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E; NephroTest Study Group. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD. Clin J Am Soc Nephrol 2015;10:957-64. [PMID: 25979978 DOI: 10.2215/CJN.08540814] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
218 Suzuki S, Furuya A, Oshima M, Amamiya S, Nakao A, Wada K, Okuhara K, Hayano S, Imamoto A, Matsuo K, Tanahashi Y, Azuma H, Koga M. Age-adjusted glycated albumin accurately reflects blood glucose in patients with neonatal diabetes mellitus: comparison with calculated glycated albumin determined by past blood glucose concentrations. Ann Clin Biochem 2016;53:117-23. [DOI: 10.1177/0004563215589382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
219 Hwang JS, Kim SJ, Bamne AB, Na YG, Kim TK. Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes? Clin Orthop Relat Res 2015;473:1726-31. [PMID: 25404402 DOI: 10.1007/s11999-014-4056-1] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 11.3] [Reference Citation Analysis]
220 Hanssen NM, Russell N, Cooper ME. Recent advances in glucose-lowering treatment to reduce diabetic kidney disease. Expert Opin Pharmacother 2015;16:1325-33. [PMID: 25912195 DOI: 10.1517/14656566.2015.1041502] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
221 Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol 2008;61:977-82. [PMID: 18755721 DOI: 10.1136/jcp.2007.054304] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
222 Kang X, Wang C, Chen D, Lv L, Liu G, Xiao J, Yang Y, He L, Chen L, Li X, Tian H, Jia W, Ran X. Contributions of Basal Glucose and Postprandial Glucose Concentrations to Hemoglobin A1c in the Newly Diagnosed Patients with Type 2 Diabetes--the Preliminary Study. Diabetes Technol Ther 2015;17:445-8. [PMID: 25826625 DOI: 10.1089/dia.2014.0327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
223 Zhang Y, Hu G, Zhang L, Mayo R, Chen L. A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults. PLoS One 2015;10:e0120382. [PMID: 25790106 DOI: 10.1371/journal.pone.0120382] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
224 Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6:109-120. [PMID: 25821639 DOI: 10.14336/AD.2014.0305] [Cited by in Crossref: 361] [Cited by in F6Publishing: 371] [Article Influence: 45.1] [Reference Citation Analysis]
225 Gerber SM, Stickle DF, Ahmed I, Jabbour SA. Glycated hemoglobin, serum proteins, and other markers as tools for monitoring. In: Defronzo RA, Ferrannini E, Zimmet P, Alberti KGMM, editors. International Textbook of Diabetes Mellitus. Chichester: John Wiley & Sons, Ltd; 2015. pp. 853-71. [DOI: 10.1002/9781118387658.ch59] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
226 Aitken JP, Ortiz C, Morales-Bozo I, Rojas-Alcayaga G, Baeza M, Beltran C, Escobar A. α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus. Dis Markers 2015;2015:128653. [PMID: 25821337 DOI: 10.1155/2015/128653] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
227 Li W, Liu Y, Lu X, Huang Y, Liu Y, Cheng S, Duan Y. A cross-sectional study of breath acetone based on diabetic metabolic disorders. J Breath Res 2015;9:016005. [PMID: 25719511 DOI: 10.1088/1752-7155/9/1/016005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
228 Goderis G, Van Casteren V, Declercq E, Bossuyt N, Van Den Broeke C, Vanthomme K, Moreels S, Nobels F, Mathieu C, Buntinx F. Care trajectories are associated with quality improvement in the treatment of patients with uncontrolled type 2 diabetes: A registry based cohort study. Prim Care Diabetes 2015;9:354-61. [PMID: 25709079 DOI: 10.1016/j.pcd.2015.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
229 Danese E, Montagnana M, Nouvenne A, Lippi G. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes. J Diabetes Sci Technol 2015;9:169-76. [PMID: 25591856 DOI: 10.1177/1932296814567227] [Cited by in Crossref: 98] [Cited by in F6Publishing: 100] [Article Influence: 12.3] [Reference Citation Analysis]
230 Fukami K, Shibata R, Nakayama H, Yamada K, Okuda S, Koga M. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Ann Clin Biochem 2015;52:488-96. [DOI: 10.1177/0004563214568162] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
231 Schäffler A, Bollheimer C, Büttner R, Girlich C, Aslanidis C, Dietmaier W, Bala M, Guralnik V, Karrasch T, Schneider S. Kohlenhydratstoffwechsel. Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel 2015. [DOI: 10.1007/978-3-662-47480-8_2] [Reference Citation Analysis]
232 Miller JD. Evaluation and Management of the Newly Diagnosed Patient with Type-2 Diabetes. A Case-Based Guide to Clinical Endocrinology 2015. [DOI: 10.1007/978-1-4939-2059-4_42] [Reference Citation Analysis]
233 Ang SH, Thevarajah M, Alias Y, Khor SM. Current aspects in hemoglobin A1c detection: A review. Clinica Chimica Acta 2015;439:202-11. [DOI: 10.1016/j.cca.2014.10.019] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
234 Nittala MG, Keane PA, Zhang K, Sadda SR. Risk factors for proliferative diabetic retinopathy in a Latino American population. Retina. 2014;34:1594-1599. [PMID: 24662751 DOI: 10.1097/iae.0000000000000117] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
235 Kim J, Kwon S. Effect of Yanggyuksanhwa-tang on non-insulin-dependent diabetes mellitus unresponsive to oral hypoglycemic agents: a case report. Chin J Integr Med 2015;21:157-60. [PMID: 25523601 DOI: 10.1007/s11655-014-2071-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Kitamura T, Otsuki M, Tamada D, Tabuchi Y, Mukai K, Morita S, Kasayama S, Bando Y, Shimomura I, Koga M. Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome. Clinical Biochemistry 2014;47:279-82. [DOI: 10.1016/j.clinbiochem.2014.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
237 Martín-vaquero P, Martínez-brocca MA, García-lópez JM. Documento de posicionamiento sobre la eficiencia de las tecnologías aplicadas al manejo de la diabetes. Endocrinología y Nutrición 2014;61:e45-63. [DOI: 10.1016/j.endonu.2014.08.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
238 Hussain Z, Yusoff ZM, Sulaiman SA. A study exploring the association of attitude and treatment satisfaction with glycaemic level among gestational diabetes mellitus patients. Prim Care Diabetes 2015;9:275-82. [PMID: 25457621 DOI: 10.1016/j.pcd.2014.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
239 Ki M, Baek S, Yun YD, Kim N, Hyde M, Na B. Age-related differences in diabetes care outcomes in Korea: a retrospective cohort study. BMC Geriatr 2014;14:111. [PMID: 25319086 DOI: 10.1186/1471-2318-14-111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
240 Tahara Y, Kido H, Nagamatsu A, Tamura Y, Nishiyama K. Cycling of hemoglobin A1c associated with hemoglobin cycling in diabetic patients under hemodialysis and its theoretical simulation. Diabetol Int 2015;6:219-25. [DOI: 10.1007/s13340-014-0191-x] [Reference Citation Analysis]
241 Beltrán del Río M, Georgiev GI, Cercone R, Tiwari M, Rilo HL. Continuous glucose monitoring analysis as predictor of islet yield and insulin requirements in autologous islet transplantation after complete pancreatectomy. J Diabetes Sci Technol 2014;8:1097-104. [PMID: 25190081 DOI: 10.1177/1932296814548702] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
242 Williams LK, Padhukasahasram B, Ahmedani BK, Peterson EL, Wells KE, González Burchard E, Lanfear DE. Differing effects of metformin on glycemic control by race-ethnicity. J Clin Endocrinol Metab 2014;99:3160-8. [PMID: 24921653 DOI: 10.1210/jc.2014-1539] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 5.2] [Reference Citation Analysis]
243 Suh S, Joung J, Jin S, Kim M, Bae J, Park H, Lee M, Lee M, Kim J. Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control. Diabetes & Metabolism 2014;40:272-7. [DOI: 10.1016/j.diabet.2014.01.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
244 Martín-vaquero P, Martínez-brocca MA, García-lópez JM. Documento de posicionamiento sobre la eficiencia de las tecnologías aplicadas al manejo de la diabetes. Avances en Diabetología 2014;30:131-149. [DOI: 10.1016/j.avdiab.2014.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
245 Peng JZ, Denney WS, Musser BJ, Liu R, Tsai K, Fang L, Reitman ML, Troyer MD, Engel SS, Xu L, Stoch A, Stone JA, Kowalski KG. A semi-mechanistic model for the effects of a novel glucagon receptor antagonist on glucagon and the interaction between glucose, glucagon, and insulin applied to adaptive phase II design. AAPS J 2014;16:1259-70. [PMID: 25160589 DOI: 10.1208/s12248-014-9648-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
246 Flory JH, Small DS, Cassano PA, Brillon DJ, Mushlin AI, Hennessy S. Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin. J Comp Eff Res 2014;3:29-39. [PMID: 24345255 DOI: 10.2217/cer.13.87] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
247 Barua A, Acharya J, Ghaskadbi S, Goel P. The relationship between fasting plasma glucose and HbA1c during intensive periods of glucose control in antidiabetic therapy. J Theor Biol 2014;363:158-63. [PMID: 25158164 DOI: 10.1016/j.jtbi.2014.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
248 Hatzenbuehler ML, Slopen N, McLaughlin KA. Stressful life events, sexual orientation, and cardiometabolic risk among young adults in the United States. Health Psychol 2014;33:1185-94. [PMID: 25133830 DOI: 10.1037/hea0000126] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
249 Hussain Z, Yusoff ZM, Sulaiman SA. Evaluation of knowledge regarding gestational diabetes mellitus and its association with glycaemic level: A Malaysian study. Prim Care Diabetes 2015;9:184-90. [PMID: 25132140 DOI: 10.1016/j.pcd.2014.07.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
250 Gomez AM, Umpierrez GE. Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol 2014;8:930-6. [PMID: 25125454 DOI: 10.1177/1932296814546025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
251 Wu C, Lin H, Chang K, Mai JD, Shiesh S, Lee G. Measurement of glycated hemoglobin levels using an integrated microfluidic system. Microfluid Nanofluid 2015;18:613-21. [DOI: 10.1007/s10404-014-1460-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
252 Xia D, McShine R, Berg AH. Misleading hemoglobin A1c levels in a patient with paroxysmal nocturnal hemoglobinuria. Am J Clin Pathol 2014;142:261-5. [PMID: 25015870 DOI: 10.1309/AJCPTK1HPR2KULJU] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
253 Takenga C, Berndt RD, Musongya O, Kitero J, Katoke R, Molo K, Kazingufu B, Meni M, Vikandy M, Takenga H. An ICT-Based Diabetes Management System Tested for Health Care Delivery in the African Context. Int J Telemed Appl 2014;2014:437307. [PMID: 25136358 DOI: 10.1155/2014/437307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
254 Williams ME. Hemoglobin A1c in the ESRD Population: Status Report. Semin Dial 2014;27:559-62. [DOI: 10.1111/sdi.12276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
255 Møller JB, Kristensen NR, Klim S, Karlsson MO, Ingwersen SH, Kjellsson MC. Methods for Predicting Diabetes Phase III Efficacy Outcome From Early Data: Superior Performance Obtained Using Longitudinal Approaches. CPT Pharmacometrics Syst Pharmacol 2014;3:e122. [PMID: 24988185 DOI: 10.1038/psp.2014.20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
256 Lorenzo-Medina M, De-La-Iglesia S, Ropero P, Nogueira-Salgueiro P, Santana-Benitez J. Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method. J Diabetes Sci Technol 2014;8:1168-76. [PMID: 25355712 DOI: 10.1177/1932296814538774] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
257 Olver TD, Mcdonald MW, Grisé KN, Dey A, Allen MD, Medeiros PJ, Lacefield JC, Jackson DN, Rice CL, Melling CWJ, Noble EG, Shoemaker JK. Exercise training enhances insulin-stimulated nerve arterial vasodilation in rats with insulin-treated experimental diabetes. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2014;306:R941-50. [DOI: 10.1152/ajpregu.00508.2013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
258 Dalan R, Earnest A, Leow MK. Ethnic variation in the correlation between fasting glucose concentration and glycated hemoglobin (HbA1c). Endocr Pract 2013;19:812-7. [PMID: 23757612 DOI: 10.4158/EP12417.OR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
259 S T K, B S N, V A, G CM, Gowdaiah PK. COMPARATIVE STUDY OF GLYCOSYLATED HAEMOGLOBIN WITH BLOOD GLUCOSE LEVELS IN THE DIAGNOSIS OF DIABETES MELLITUS. jemds 2014;3:6435-6443. [DOI: 10.14260/jemds/2014/2760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
260 Huang J, Ou HY, Karnchanasorn R, Samoa R, Chuang LM, Chiu KC, Feng W. Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus. Endocrine 2015;48:511-8. [PMID: 24895042 DOI: 10.1007/s12020-014-0301-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
261 Kesavadev J, Sadikot S, Wangnoo S, Kannampilly J, Saboo B, Aravind SR, Kalra S, Makkar BM, Maji D, Saikia M, Anjana RM, Rajput R, Singh SK, Shah S, Dhruv U, Vishwanathan V. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM. Diabetes Metab Syndr 2014;8:187-95. [PMID: 25200925 DOI: 10.1016/j.dsx.2014.04.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
262 Di Prospero NA, Artis E, Andrade-Gordon P, Johnson DL, Vaccaro N, Xi L, Rothenberg P. CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Diabetes Obes Metab 2014;16:1055-64. [PMID: 24798870 DOI: 10.1111/dom.12309] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
263 Olver TD, Grisé KN, McDonald MW, Dey A, Allen MD, Rice CL, Lacefield JC, Melling CJ, Noble EG, Shoemaker JK. The relationship between blood pressure and sciatic nerve blood flow velocity in rats with insulin-treated experimental diabetes. Diab Vasc Dis Res 2014;11:281-9. [PMID: 24853907 DOI: 10.1177/1479164114533357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
264 Hayashi N, Iida T, Yamada T, Okuma K, Takehara I, Yamamoto T, Yamada K, Tokuda M. Study on the Postprandial Blood Glucose Suppression Effect of D -Psicose in Borderline Diabetes and the Safety of Long-Term Ingestion by Normal Human Subjects. Bioscience, Biotechnology, and Biochemistry 2014;74:510-9. [DOI: 10.1271/bbb.90707] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 13.1] [Reference Citation Analysis]
265 Sacco WP, Bykowski CA, Mayhew LL. Pain and functional impairment as mediators of the link between medical symptoms and depression in type 2 diabetes. Int J Behav Med 2013;20:22-9. [PMID: 22198562 DOI: 10.1007/s12529-011-9210-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
266 Florkowski C, Crooke M, Reed M. Implementation of the HbA1c IFCC unit — from the laboratory to the consumer: The New Zealand experience. Clinica Chimica Acta 2014;432:157-61. [DOI: 10.1016/j.cca.2013.10.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
267 Liu X, Zheng P, Wang X, Dai G, Cheng H, Zhang Z, Hua R, Niu X, Shi J, An Y. A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cell Res Ther 2014;5:57. [PMID: 24759263 DOI: 10.1186/scrt446] [Cited by in Crossref: 93] [Cited by in F6Publishing: 100] [Article Influence: 10.3] [Reference Citation Analysis]
268 Tousson E, Salama A, Ibrahim W, El-nimr T, A. Abd El- M. Effect of Myrrh Extract (Mirazid®) on Experimentally Diabetic Rats. Pharmacologia 2014;5:135-142. [DOI: 10.5567/pharmacologia.2014.135.142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
269 Zhao C, Luo Q, He F, Peng F, Xia X, Huang F, Yu X. Establishing HbA1c -mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysis. Diabet Med 2014;31:813-20. [PMID: 24628621 DOI: 10.1111/dme.12432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
270 Koga M. Glycated albumin; clinical usefulness. Clin Chim Acta. 2014;433:96-104. [PMID: 24631132 DOI: 10.1016/j.cca.2014.03.001] [Cited by in Crossref: 119] [Cited by in F6Publishing: 126] [Article Influence: 13.2] [Reference Citation Analysis]
271 Coelho S, Rodrigues A. Hemoglobin A1c in Patients on Peritoneal Dialysis: How Should We Interpret It?: Hemoglobin A1c in Peritoneal Dialysis. Ther Apher Dial 2014;18:375-82. [DOI: 10.1111/1744-9987.12166] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
272 Williams ME, Garg R. Glycemic Management in ESRD and Earlier Stages of CKD. American Journal of Kidney Diseases 2014;63:S22-38. [DOI: 10.1053/j.ajkd.2013.10.049] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
273 Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, Drechsler C, Lacatus R, Vanholder R, Nistor I, Bilo H, Bolignano D, Couchoud C, Covic A, Coentrao L, Sutter JD, Drechsler C, Gnudi L, Goldsmith D, Heaf J, Heimburger O, Jager K, Nacak H, Nistor I, Soler M, Tomson C, Vanhuffel L, Biesen WV, Laecke SV, Weekers L, Wiecek A; for the European Renal Best Practice Guideline Development Group on Diabetes in Advanced CKD. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrology Dialysis Transplantation 2014;29:2167-77. [DOI: 10.1093/ndt/gfu006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 7.3] [Reference Citation Analysis]
274 Toffanin C, Sandri A, Messori M, Cobelli C, Magni L. Automatic adaptation of basal therapy for Type 1 diabetic patients: a Run-to-Run approach. IFAC Proceedings Volumes 2014;47:2070-5. [DOI: 10.3182/20140824-6-za-1003.02462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
275 Hill CJ, Maxwell AP, Cardwell CR, Freedman BI, Tonelli M, Emoto M, Inaba M, Hayashino Y, Fukuhara S, Okada T, Drechsler C, Wanner C, Casula A, Adler AI, Lamina C, Kronenberg F, Streja E, Kalantar-zadeh K, Fogarty DG. Glycated Hemoglobin and Risk of Death in Diabetic Patients Treated With Hemodialysis: A Meta-analysis. American Journal of Kidney Diseases 2014;63:84-94. [DOI: 10.1053/j.ajkd.2013.06.020] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 6.4] [Reference Citation Analysis]
276 Kabisch S, Kulzer B, Pfeiffer AFH, Pfohl M, Schifferdecker E, Schulze MB, Weitgasser R. Allgemeine Grundlagen des Diabetes mellitus. Diabetologie kompakt 2014. [DOI: 10.1007/978-3-642-41358-2_1] [Reference Citation Analysis]
277 Hodeck K, Heitel S, Trept S, Uhlig M, Carstensen S, Schulze G, Reuber-menze L, Vosseler A, Assenheimer B, Bahrmann A, Ratzmann A, Fanghänel J, Pannek J, Hartmann-eisele S, Woltmann A, Övermöhle B, Althaus M. Pflege des älteren Diabetes-Patienten. Pflegewissen Diabetes 2014. [DOI: 10.1007/978-3-642-38409-7_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
278 Goderis G, Van Pottelbergh G, Truyers C, Van Casteren V, De Clercq E, Van Den Broeke C, Buntinx F. Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study. BMJ Open 2013;3:e004029. [PMID: 24381258 DOI: 10.1136/bmjopen-2013-004029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
279 Zhou J, Mo Y, Li H, Ran X, Yang W, Li Q, Peng Y, Li Y, Gao X, Luan X, Wang W, Xie Y, Jia W. Relationship between HbA1c and continuous glucose monitoring in Chinese population: a multicenter study. PLoS One 2013;8:e83827. [PMID: 24376762 DOI: 10.1371/journal.pone.0083827] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
280 . Surveillance du contrôle de la glycémie. Canadian Journal of Diabetes 2013;37:S613-4. [DOI: 10.1016/j.jcjd.2013.03.410] [Reference Citation Analysis]
281 Lerner N, Shani M, Vinker S. Predicting type 2 diabetes mellitus using haemoglobin A1c: A community-based historic cohort study. European Journal of General Practice 2014;20:100-6. [DOI: 10.3109/13814788.2013.826642] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
282 Simões HG, Asano RY, Sales MM, Browne RA, Arsa G, Motta-Santos D, Puga GM, Lima LC, Campbell CS, Franco OL. Type 2 diabetes elicits lower nitric oxide, bradykinin concentration and kallikrein activity together with higher DesArg(9)-BK and reduced post-exercise hypotension compared to non-diabetic condition. PLoS One 2013;8:e80348. [PMID: 24265812 DOI: 10.1371/journal.pone.0080348] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
283 Matheka DM, Kilonzo JM, Munguti CM, Mwangi PW. Pattern, knowledge and practices of HbA1C testing among diabetic patients in a Kenyan tertiary referral hospital. Global Health 2013;9:55. [PMID: 24192011 DOI: 10.1186/1744-8603-9-55] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
284 Häring HU, Merker L, Seewaldt-Becker E, Weimer M, Meinicke T, Woerle HJ, Broedl UC; EMPA-REG METSU Trial Investigators. Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial. Diabetes Care 2013;36:3396-404. [PMID: 23963895 DOI: 10.2337/dc12-2673] [Cited by in Crossref: 267] [Cited by in F6Publishing: 287] [Article Influence: 26.7] [Reference Citation Analysis]
285 Caldeira D, de Castro Linhares A, Bettega M, Clemente AC, Gama MP, Rossi PR. A1C as a diabetes diagnosis method: experience in a coronary ICU. Journal of Cardiovascular Medicine 2013;14:827-32. [DOI: 10.2459/jcm.0b013e3283600a1f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
286 Beisswenger PJ, Howell SK, Russell GB, Miller ME, Rich SS, Mauer M. Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes Care 2013;36:3234-9. [PMID: 23780945 DOI: 10.2337/dc12-2689] [Cited by in Crossref: 92] [Cited by in F6Publishing: 92] [Article Influence: 9.2] [Reference Citation Analysis]
287 Shi L, Ye X, Lu M, Wu EQ, Sharma H, Thomason D, Fonseca VA. Clinical and economic benefits associated with the achievement of both HbA1c and LDL cholesterol goals in veterans with type 2 diabetes. Diabetes Care 2013;36:3297-304. [PMID: 23801723 DOI: 10.2337/dc13-0149] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
288 Berard LD, Blumer I, Houlden R, Miller D, Woo V. Surveillance du contrôle de la glycémie. Canadian Journal of Diabetes 2013;37:S398-S402. [DOI: 10.1016/j.jcjd.2013.07.037] [Reference Citation Analysis]
289 Khan HA, Ola MS, Alhomida AS, Sobki SH, Khan SA. Evaluation of HbA1c criteria for diagnosis of diabetes mellitus: a retrospective study of 12 785 type 2 Saudi male patients. Endocr Res 2014;39:61-5. [PMID: 24067131 DOI: 10.3109/07435800.2013.828740] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
290 Beisswenger PJ, Howell SK, Russell G, Miller ME, Rich SS, Mauer M. Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids 2014;46:311-9. [DOI: 10.1007/s00726-013-1533-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
291 Chalew SA, McCarter RJ, Hempe JM. Biological variation and hemoglobin A1c: relevance to diabetes management and complications. Pediatr Diabetes 2013;14:391-8. [PMID: 23952704 DOI: 10.1111/pedi.12055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
292 Yang J, Yu J, Rudi Strickler J, Chang W, Gunasekaran S. Nickel nanoparticle–chitosan-reduced graphene oxide-modified screen-printed electrodes for enzyme-free glucose sensing in portable microfluidic devices. Biosensors and Bioelectronics 2013;47:530-8. [DOI: 10.1016/j.bios.2013.03.051] [Cited by in Crossref: 152] [Cited by in F6Publishing: 155] [Article Influence: 15.2] [Reference Citation Analysis]
293 Zehetner C, Kirchmair R, Kralinger M, Kieselbach G. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy. Acta Ophthalmol 2013;91:e470-3. [PMID: 23452413 DOI: 10.1111/aos.12081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
294 Koga M, Suzuki S, Matsuo K, Tanahashi Y, Azuma H, Kasayama S. Calculation of HbA1c and glycated albumin from serially measured self-monitored blood glucose in patients with type 1 diabetes mellitus. Clin Chim Acta 2013;425:188-91. [PMID: 23933122 DOI: 10.1016/j.cca.2013.07.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
295 Mohamed H, Al-Lenjawi B, Amuna P, Zotor F, Elmahdi H. Culturally sensitive patient-centred educational programme for self-management of type 2 diabetes: a randomized controlled trial. Prim Care Diabetes. 2013;7:199-206. [PMID: 23830727 DOI: 10.1016/j.pcd.2013.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
296 Cosson E, Banu I, Cussac-Pillegand C, Chen Q, Chiheb S, Jaber Y, Nguyen MT, Charnaux N, Valensi P. Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes. Diabetes Care 2013;36:2070-6. [PMID: 23378625 DOI: 10.2337/dc12-1780] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
297 Kitamura T, Otsuki M, Tamada D, Tabuchi Y, Mukai K, Morita S, Kasayama S, Shimomura I, Koga M. Glycated albumin is set lower in relation to plasma glucose levels in patients with Cushing's syndrome. Clin Chim Acta 2013;424:164-7. [PMID: 23792199 DOI: 10.1016/j.cca.2013.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
298 Hatzenbuehler ML, McLaughlin KA, Slopen N. Sexual orientation disparities in cardiovascular biomarkers among young adults. Am J Prev Med 2013;44:612-21. [PMID: 23683979 DOI: 10.1016/j.amepre.2013.01.027] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 9.5] [Reference Citation Analysis]
299 Monitoring Glycemic Control. Canadian Journal of Diabetes 2013;37:S304-S305. [DOI: 10.1016/j.jcjd.2013.02.008] [Reference Citation Analysis]
300 Wu S, Yi F, Zhou C, Zhang M, Zhu Y, Tuniyazi Y, Huang L, Huang X, Wang F, Bi Y, Ning G. HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China (HbA1c). J Diabetes 2013;5:282-90. [PMID: 23452328 DOI: 10.1111/1753-0407.12035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
301 Han HS, Kang SB. Relations between long-term glycemic control and postoperative wound and infectious complications after total knee arthroplasty in type 2 diabetics. Clin Orthop Surg 2013;5:118-23. [PMID: 23730475 DOI: 10.4055/cios.2013.5.2.118] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
302 Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes 2013;14:159-67. [PMID: 23448393 DOI: 10.1111/pedi.12025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
303 Gaikwad SP, Gurav AN, Shete AR, Desarda HM. Effect of scaling and root planing combined with systemic doxycycline therapy on glycemic control in diabetes mellitus subjects with chronic generalized periodontitis: a clinical study. J Periodontal Implant Sci. 2013;43:79-86. [PMID: 23678391 DOI: 10.5051/jpis.2013.43.2.79] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
304 Anguizola J, Joseph KS, Barnaby OS, Matsuda R, Alvarado G, Clarke W, Cerny RL, Hage DS. Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin. Anal Chem 2013;85:4453-60. [PMID: 23544441 DOI: 10.1021/ac303734c] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
305 Song KH, Kim JM, Noh JH, Park Y, Son HS, Min KW, Ko KS. Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study. Diabetes Metab J 2013;37:117-24. [PMID: 23641352 DOI: 10.4093/dmj.2013.37.2.117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
306 Hoshino J, Mehrotra R, Rhee CM, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Molnar MZ, Kalantar-Zadeh K. Using hemoglobin A1c to derive mean blood glucose in peritoneal dialysis patients. Am J Nephrol 2013;37:413-20. [PMID: 23594745 DOI: 10.1159/000349929] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
307 Sharma RP. Blood chromatin as a biosensor of the epigenetic milieu: a tool for studies in living psychiatric patients. Epigenomics 2012;4:551-9. [PMID: 23130836 DOI: 10.2217/epi.12.46] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
308 Khan S, Raghuram GV, Pathak N, Jain SK, Chandra DH, Mishra PK. Impairment of mitochondrial-nuclear cross talk in neutrophils of patients with type 2 diabetes mellitus. Indian J Clin Biochem 2014;29:38-44. [PMID: 24478547 DOI: 10.1007/s12291-013-0321-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
309 Berard LD, Blumer I, Houlden R, Miller D, Woo V. Monitoring Glycemic Control. Canadian Journal of Diabetes 2013;37:S35-9. [DOI: 10.1016/j.jcjd.2013.01.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
310 Hoshino J, Molnar MZ, Yamagata K, Ubara Y, Takaichi K, Kovesdy CP, Kalantar-Zadeh K. Developing an HbA(1c)-based equation to estimate blood glucose in maintenance hemodialysis patients. Diabetes Care 2013;36:922-7. [PMID: 23238664 DOI: 10.2337/dc12-1019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
311 Garg R, Williams ME. Diabetes management in the kidney patient. Med Clin North Am. 2013;97:135-156. [PMID: 23290735 DOI: 10.1016/j.mcna.2012.11.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
312 Macedo Gde O, Novaes AB, Souza SL, Taba M, Palioto DB, Grisi MF. Additional effects of aPDT on nonsurgical periodontal treatment with doxycycline in type II diabetes: a randomized, controlled clinical trial. Lasers Med Sci. 2014;29:881-886. [PMID: 23474741 DOI: 10.1007/s10103-013-1285-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
313 Zhernovaya OS, Tuchin VV, Meglinski IV. Monitoring of blood proteins glycation by refractive index and spectral measurements. Laser Phys Lett 2008;5:460-4. [DOI: 10.1002/lapl.200810007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 4.8] [Reference Citation Analysis]
314 Mortada R, Comerford K, Kallail KJ, Karakas SE. Utility of Hemoglobin-A1C in Nondiabetic Women With Polycystic Ovary Syndrome. Endocrine Practice 2013;19:284-9. [DOI: 10.4158/ep12123.or] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
315 Hendricks M, Monaghan M, Soutor S, Chen R, Holmes CS. A profile of self-care behaviors in emerging adults with type 1 diabetes. Diabetes Educ 2013;39:195-203. [PMID: 23396184 DOI: 10.1177/0145721713475840] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
316 Datz N. Der Traum vom künstlichen Pankreas. Pädiatrie 2013;25:42-48. [DOI: 10.1007/s15014-013-0023-7] [Reference Citation Analysis]
317 Monaghan M, Horn IB, Alvarez V, Cogen FR, Streisand R. Authoritative parenting, parenting stress, and self-care in pre-adolescents with type 1 diabetes. J Clin Psychol Med Settings 2012;19:255-61. [PMID: 22350495 DOI: 10.1007/s10880-011-9284-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
318 Agarwal N, Biswas D, Joshi S, Deshpande V. Correlation between glycated haemoglobin and glucose testing for diabetes mellitus screening. Indian J Med Sci 2013;67:149. [DOI: 10.4103/0019-5359.125875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
319 Schäffler A, Bollheimer C, Büttner R, Girlich C, Aslanidis C, Dietmaier W, Bala M, Guralnik V, Karrasch T, Wurm S. Kohlenhydratstoffwechsel. Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel 2013. [DOI: 10.1007/978-3-642-29690-1_2] [Reference Citation Analysis]
320 Williams ME, Stanton R. Nutritional and Metabolic Management of the Diabetic Patient with Chronic Kidney Disease and Chronic Renal Failure. Nutritional Management of Renal Disease 2013. [DOI: 10.1016/b978-0-12-391934-2.00031-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
321 Zhang X, Schneck K, Bue-Valleskey J, Yeo KP, Heathman M, Sinha V. Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator. J Pharmacokinet Pharmacodyn 2013;40:53-65. [PMID: 23263772 DOI: 10.1007/s10928-012-9286-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
322 Ruano L, Alves I, Barreto R, Araújo I, Veira C, Cruz VT. Ischemic vagus nuclei lesions and hyperglycemia: a study in 26 patients with lateral medullary infarction and matched controls. Cerebrovasc Dis 2012;34:406-10. [PMID: 23221320 DOI: 10.1159/000343654] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
323 Rodríguez-Segade S, Rodríguez J, García Lopez JM, Casanueva FF, Camiña F. Estimation of the glycation gap in diabetic patients with stable glycemic control. Diabetes Care 2012;35:2447-50. [PMID: 22961579 DOI: 10.2337/dc11-2450] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
324 Okosun IS, Davis-smith M, Paul Seale J, Ngulefac J. Applicability of a combination of hemoglobin A 1c and fasting plasma glucose in population-based prediabetes screening: Screening for prediabetes using Hb A1c. Journal of Diabetes 2012;4:407-16. [DOI: 10.1111/j.1753-0407.2012.00188.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
325 Kubota M, Hosoda K, Eguchi K, Furuya A, Nishijima Y, Nakao K, Kinoshita A. Videophone-based multimodal home telecare support system for patients with diabetes. Diabetol Int 2013;4:52-9. [DOI: 10.1007/s13340-012-0096-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
326 Murea M, Moran T, Russell GB, Shihabi ZK, Byers JR, Andries L, Bleyer AJ, Freedman BI. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Am J Nephrol 2012;36:488-96. [PMID: 23147746 DOI: 10.1159/000343920] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
327 Inoue K, Kashima S, Ohara C, Matsumoto M, Akimoto K. Concordance of two diabetes diagnostic criteria using fasting plasma glucose and hemoglobin A1c: the Yuport Medical Checkup Centre study. PLoS One 2012;7:e47747. [PMID: 23082207 DOI: 10.1371/journal.pone.0047747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
328 Bhansali A, Walia R, Ravi Kumar P, Ravi Kiran M, Shanmugasundar G. Accuracy of glycated haemoglobin in screening for pre-diabetes in Asian Indians-a community survey: the Chandigarh Urban Diabetes Study (CUDS): HbA 1c for detecting pre-diabetes. Diabetic Medicine 2012;29:1385-9. [DOI: 10.1111/j.1464-5491.2012.03634.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
329 Tankova T, Chakarova N, Dakovska L, Atanassova I. Assessment of HbA1c as a diagnostic tool in diabetes and prediabetes. Acta Diabetol 2012;49:371-8. [PMID: 21964885 DOI: 10.1007/s00592-011-0334-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
330 Ogawa A, Hayashi A, Kishihara E, Yoshino S, Takeuchi A, Shichiri M. New indices for predicting glycaemic variability. PLoS One. 2012;7:e46517. [PMID: 23029543 DOI: 10.1371/journal.pone.0046517] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
331 Goto M, Morita A, Goto A, Sasaki S, Aiba N, Shimbo T, Terauchi Y, Miyachi M, Noda M, Watanabe S; SCOP Study Group. Dietary glycemic index and glycemic load in relation to HbA1c in Japanese obese adults: a cross-sectional analysis of the Saku Control Obesity Program. Nutr Metab (Lond) 2012;9:79. [PMID: 22963077 DOI: 10.1186/1743-7075-9-79] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
332 Floyd B, Chandra P, Hall S, Phillips C, Alema-Mensah E, Strayhorn G, Ofili EO, Umpierrez GE. Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol 2012;6:1094-102. [PMID: 23063035 DOI: 10.1177/193229681200600513] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
333 Erejuwa OO, Sulaiman SA, Wahab MS. Honey--a novel antidiabetic agent. Int J Biol Sci 2012;8:913-34. [PMID: 22811614 DOI: 10.7150/ijbs.3697] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
334 Meetoo DD, Mcallister G, West A. Assessing glycaemic control with self-monitoring of blood glucose. Practice Nursing 2012;23:352-360. [DOI: 10.12968/pnur.2012.23.7.352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
335 Choi SH. Letter: Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea (Diabetes Metab J 2012;36:151-6). Diabetes Metab J 2012;36:251-2. [PMID: 22737666 DOI: 10.4093/dmj.2012.36.3.251] [Reference Citation Analysis]
336 Trence DL, Hirsch IB. Motherhood, apple pie, hemoglobin A(1C), and the DCCT. Endocr Pract 2012;18:78-84. [PMID: 22336443 DOI: 10.4158/ep11359.ra] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
337 Krinsley JS, Meyfroidt G, van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;151-160. [PMID: 22234163 DOI: 10.1097/mco.0b013e32834f0009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 5.9] [Reference Citation Analysis]
338 Gilowski L, Kondzielnik P, Wiench R, Płocica I, Strojek K, Krzemiński TF. Efficacy of short-term adjunctive subantimicrobial dose doxycycline in diabetic patients--randomized study. Oral Dis 2012;18:763-70. [PMID: 22621750 DOI: 10.1111/j.1601-0825.2012.01943.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
339 Ceriello A. The emerging challenge in diabetes: the "metabolic memory". Vascul Pharmacol 2012;57:133-8. [PMID: 22609133 DOI: 10.1016/j.vph.2012.05.005] [Cited by in Crossref: 108] [Cited by in F6Publishing: 99] [Article Influence: 9.8] [Reference Citation Analysis]
340 Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Nephrology (Carlton). 2012;17:182-188. [PMID: 21883672 DOI: 10.1111/j.1440-1797.2011.01517.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 6.7] [Reference Citation Analysis]
341 Aldasouqi SA, Gossain VV. Update on diabetes diagnosis: a historical review of the dilemma of the diagnostic utility of glycohemoglobin A1c and a proposal for a combined glucose-A1c diagnostic method. Ann Saudi Med 2012;32:229-35. [PMID: 22588455 DOI: 10.5144/0256-4947.2012.229] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
342 Sáenz A, Brito M, Morón I, Torralba A, García-Sanz E, Redondo J. Development and validation of a computer application to aid the physician’s decision-making process at the start of and during treatment with insulin in type 2 diabetes: a randomized and controlled trial. J Diabetes Sci Technol. 2012;6:581-588. [PMID: 22768889 DOI: 10.1177/193229681200600313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
343 Kim JK, Park JT, Oh HJ, Yoo DE, Kim SJ, Han SH, Kang SW, Choi KH, Yoo TH. Estimating average glucose levels from glycated albumin in patients with end-stage renal disease. Yonsei Med J 2012;53:578-86. [PMID: 22477003 DOI: 10.3349/ymj.2012.53.3.578] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
344 Erejuwa OO, Sulaiman SA, Ab Wahab MS. Honey: a novel antioxidant. Molecules 2012;17:4400-23. [PMID: 22499188 DOI: 10.3390/molecules17044400] [Cited by in Crossref: 165] [Cited by in F6Publishing: 175] [Article Influence: 15.0] [Reference Citation Analysis]
345 Sakamoto K, Shiba T. Discrete effects of glimepiride and metformin on preprandial and postprandial glucose and contributions to the amelioration of chronic hyperglycemia. Diabetol Int 2012;3:21-28. [DOI: 10.1007/s13340-011-0056-5] [Reference Citation Analysis]
346 Thakare N, Mukherjee R, Sinclair AM, Elsobky S, Pearce I. The Assessment and Peri-Operative Management of Diabetes Mellitus in Urological Day Case Surgery—Outcomes of the North West of England Regional Audit. British Journal of Medical and Surgical Urology 2012;5:78-83. [DOI: 10.1016/j.bjmsu.2011.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
347 Bhaktha G, Nayak BS, Mayya S, Shantaram M. Is HbA1c a risk factor for type 2 diabetic subjects without macro and micro vascular complications? Archives of Physiology and Biochemistry 2012;118:69-71. [DOI: 10.3109/13813455.2011.645837] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
348 Larger E, Lemoine AY, Gonfroy-leymarie C, Borie-swinburne C. HbA1c pour le diagnostic et le suivi du diabète: Le point de vue du diabétologue. Revue Francophone des Laboratoires 2012;2012:23-26. [DOI: 10.1016/s1773-035x(12)71326-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
349 Rhee EJ. The Effects of Postprandial Hyperglycemia on Glucose Control. J Korean Diabetes 2012;13:23. [DOI: 10.4093/jkd.2012.13.1.23] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
350 Lee JM. Pathophysiology of Postprandial Hyperglycemia. J Korean Diabetes 2012;13:15. [DOI: 10.4093/jkd.2012.13.1.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
351 . Characterization of Glucose Metabolism. Staged Diabetes Management 2011. [DOI: 10.1002/9781119950424.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
352 Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C; Diabetes Research in Children Network (DirecNet) Study Group. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Pediatr Diabetes 2011;12:690-5. [PMID: 21496193 DOI: 10.1111/j.1399-5448.2011.00764.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
353 Khan S, Raghuram GV, Bhargava A, Pathak N, Chandra DH, Jain SK, Mishra PK. Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl Res 2011;158:344-59. [PMID: 22061042 DOI: 10.1016/j.trsl.2011.08.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
354 Schröder F, Siegel E. HbA1c. Diabetologe 2011;7:487-488. [DOI: 10.1007/s11428-011-0748-2] [Reference Citation Analysis]
355 Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol 2011;5:1572-83. [PMID: 22226280 DOI: 10.1177/193229681100500634] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
356 Bozkaya G, Ozgu E, Karaca B. The association between estimated average glucose levels and fasting plasma glucose levels. Clinics (Sao Paulo) 2010;65:1077-80. [PMID: 21243275 DOI: 10.1590/s1807-59322010001100003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
357 Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol 2011;26:779-87. [PMID: 21947790 DOI: 10.1007/s10654-011-9619-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
358 Chubb SA, Van Minnen K, Davis WA, Bruce DG, Davis TM. The relationship between self-monitoring of blood glucose results and glycated haemoglobin in type 2 diabetes: the fremantle diabetes study. Diabetes Res Clin Pract 2011;94:371-6. [PMID: 21862165 DOI: 10.1016/j.diabres.2011.07.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
359 Maurer TS, Ghosh A, Haddish-Berhane N, Sawant-Basak A, Boustany-Kari CM, She L, Leininger MT, Zhu T, Tugnait M, Yang X, Kimoto E, Mascitti V, Robinson RP. Pharmacodynamic model of sodium-glucose transporter 2 (SGLT2) inhibition: implications for quantitative translational pharmacology. AAPS J 2011;13:576-84. [PMID: 21870203 DOI: 10.1208/s12248-011-9297-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
360 Forst T, Uhlig-Laske B, Ring A, Ritzhaupt A, Graefe-Mody U, Dugi KA. The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus. Diabetes Obes Metab 2011;13:542-50. [PMID: 21352464 DOI: 10.1111/j.1463-1326.2011.01386.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
361 Wilson DD, Mcallister G, West A. Assessing glycaemic control: self-monitoring of blood glucose. British Journal of Nursing 2011;20:919-25. [DOI: 10.12968/bjon.2011.20.15.919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
362 Haddadinezhad S, Ghazaleh N. Relation of fasting and postprandial and plasma glucose with hemoglobinA1c in diabetics. Int J Diabetes Dev Ctries 2010;30:8-10. [PMID: 20431799 DOI: 10.4103/0973-3930.60002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
363 Landgraf R, Kowall B, Rathmann W. HbA1c – ein Alleskönner? Diabetologe 2011;7:335-346. [DOI: 10.1007/s11428-011-0739-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
364 Shaya FT, Yan X, Lin PJ, Simoni-Wastila L, Bron M, Baran R, Donner TW. US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens (Greenwich). 2010;12:826-832. [PMID: 21029348 DOI: 10.1111/j.1751-7176.2010.00365.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
365 Monnier L, Colette C, Owens D. Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts. Diabetes Technology & Therapeutics 2011;13:S-25-32. [DOI: 10.1089/dia.2010.0239] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 5.0] [Reference Citation Analysis]
366 González Clemente JM, Cabot GL. [Assessment of glycemic control: new insights into the evaluation of the diabetic patient]. Med Clin (Barc) 2010;135 Suppl 2:15-9. [PMID: 21420533 DOI: 10.1016/S0025-7753(10)70028-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
367 Albisser AM, Inhaber F. Automation of the consensus guidelines in diabetes care: potential impact on clinical inertia. Endocr Pract 2010;16:992-1002. [PMID: 20570811 DOI: 10.4158/EP10124.OR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
368 Pajunen P, Peltonen M, Eriksson JG, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Uusitupa M, Tuomilehto J, Lindström J; Finnish Diabetes Prevention Study. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med 2011;28:36-42. [PMID: 21166843 DOI: 10.1111/j.1464-5491.2010.03183.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
369 Lippi G, Targher G. A laboratory standpoint on the role of hemoglobin A1c for the diagnosis of diabetes in childhood: more doubts than certainties? Pediatr Diabetes 2011;12:183-6. [PMID: 21129136 DOI: 10.1111/j.1399-5448.2010.00684.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
370 Jecht M. Glykohämoglobin und mittlere Glukosekonzentration bei Patienten mit Typ-1-Diabetes. Diabetologe 2011;7:197-198. [DOI: 10.1007/s11428-011-0720-1] [Reference Citation Analysis]
371 Rhee SY, Woo JT. The prediabetic period: review of clinical aspects. Diabetes Metab J 2011;35:107-16. [PMID: 21738892 DOI: 10.4093/dmj.2011.35.2.107] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
372 Neri L, Dukes J, Brennan DC, Salvalaggio PR, Seelam S, Desiraju S, Schnitzler M. Impaired renal function is associated with worse self-reported outcomes after kidney transplantation. Qual Life Res 2011;20:1689-98. [PMID: 21479956 DOI: 10.1007/s11136-011-9905-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
373 Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH. Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011;34:944-9. [PMID: 21335372 DOI: 10.2337/dc10-0644] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.1] [Reference Citation Analysis]
374 Giordano C, Amato MC, Ciresi A, Citarrella R, Mantione L, Accidenti M, Pantò F, Guarnotta V, Allotta ML, Criscimanna A, Galluzzo A. Predictors of microvascular complications in type 1 diabetic patients at onset: the role of metabolic memory. Eur J Intern Med 2011;22:266-74. [PMID: 21570646 DOI: 10.1016/j.ejim.2011.02.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
375 Lapolla A, Porcu S, Traldi P. Some views on proteomics in diabetes. Clin Chem Lab Med 2011;49:943-57. [PMID: 21410413 DOI: 10.1515/CCLM.2011.151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
376 Erejuwa OO, Sulaiman SA, Wahab MS, Sirajudeen KN, Salleh MS, Gurtu S. Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats. Int J Biol Sci 2011;7:244-52. [PMID: 21448302 DOI: 10.7150/ijbs.7.244] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 5.3] [Reference Citation Analysis]
377 Zarowitz BJ. The ADA Focus on Diabetes 2011. Geriatric Nursing 2011;32:119-122. [DOI: 10.1016/j.gerinurse.2011.01.003] [Reference Citation Analysis]
378 Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care 2011;34:540-4. [PMID: 21266647 DOI: 10.2337/dc10-1054] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
379 Marcovecchio ML, Lucantoni M, Chiarelli F. Role of chronic and acute hyperglycemia in the development of diabetes complications. Diabetes Technol Ther 2011;13:389-94. [PMID: 21299400 DOI: 10.1089/dia.2010.0146] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
380 Valdés S, Botas P, Delgado E, Álvarez F, Díaz-cadórniga F. HbA1c in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998–2005). Diabetes & Metabolism 2011;37:27-32. [DOI: 10.1016/j.diabet.2010.07.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
381 Shima K, Komatsu M, Kawahara K, Minaguchi J, Kawashima S. Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on haemodialysis. Nephrology (Carlton). 2010;15:632-638. [PMID: 20883284 DOI: 10.1111/j.1440-1797.2010.01273.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
382 Bouzid K, Bahlous A, Hamdane Y, Chelbi A, Mohsni A, Zerelli L, Ben Hamida A, Abdelmoula J. Dosage de l’hémoglobine glyquée dans une population tunisienne : valeurs de référence chez les non diabétiques et corrélations avec les glycémies à jeun chez les diabétiques. Immuno-analyse & Biologie Spécialisée 2011;26:19-22. [DOI: 10.1016/j.immbio.2010.07.001] [Reference Citation Analysis]
383 Mirani M, Berra C, Finazzi S, Calvetta A, Radaelli MG, Favareto F, Graziani G, Badalamenti S. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis. Diabetes Technol Ther. 2010;12:749-753. [PMID: 20809678 DOI: 10.1089/dia.2010.0052] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
384 Kirkham S, Akilen R, Sharma S, Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab. 2009;11:1100-1113. [PMID: 19930003 DOI: 10.1111/j.1463-1326.2009.01094.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 5.3] [Reference Citation Analysis]
385 Sales MM, Campbell CS, Morais PK, Ernesto C, Soares-Caldeira LF, Russo P, Motta DF, Moreira SR, Nakamura FY, Simões HG. Noninvasive method to estimate anaerobic threshold in individuals with type 2 diabetes. Diabetol Metab Syndr 2011;3:1. [PMID: 21226946 DOI: 10.1186/1758-5996-3-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
386 Buse JB, Polonsky KS, Burant CF. Type 2 Diabetes Mellitus. Williams Textbook of Endocrinology 2011. [DOI: 10.1016/b978-1-4377-0324-5.00031-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
387 Koga M, Hashimoto K, Murai J, Saito H, Mukai M, Ikegame K, Ogawa H, Kasayama S. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clinica Chimica Acta 2011;412:253-7. [DOI: 10.1016/j.cca.2010.10.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
388 Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH. No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol 2011;5:86-92. [PMID: 21303629 DOI: 10.1177/193229681100500112] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
389 Khan MI, Weinstock RS. Carbohydrates. Henry's Clinical Diagnosis and Management by Laboratory Methods 2011. [DOI: 10.1016/b978-1-4377-0974-2.00016-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
390 American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34 Suppl 1:S11-61. [PMID: 21193625 DOI: 10.2337/dc11-S011] [Cited by in Crossref: 1833] [Cited by in F6Publishing: 2046] [Article Influence: 152.8] [Reference Citation Analysis]
391 Hill AN, Appel SJ. Diagnosing diabetes with A1C: implications and considerations for measurement and surrogate markers. Nurse Pract 2010;35:16-23; quiz 23-4. [PMID: 20827232 DOI: 10.1097/01.NPR.0000388206.16357.02] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
392 Rodríguez-Segade S, Rodríguez J, Cabezas-Agricola JM, Casanueva FF, Camiña F. Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c). Clin Chem 2011;57:264-71. [PMID: 21147957 DOI: 10.1373/clinchem.2010.144949] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
393 Beisswenger PJ. Glycation and biomarkers of vascular complications of diabetes. Amino Acids 2012;42:1171-83. [PMID: 21042818 DOI: 10.1007/s00726-010-0784-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
394 Davey RJ, Jones TW, Fournier PA. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus. J Diabetes Sci Technol 2010;4:1457-64. [PMID: 21129341 DOI: 10.1177/193229681000400620] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
395 Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS. Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010;33:2184-9. [PMID: 20639452 DOI: 10.2337/dc10-0433] [Cited by in Crossref: 166] [Cited by in F6Publishing: 172] [Article Influence: 12.8] [Reference Citation Analysis]
396 Kitzmiller JL, Wallerstein R, Correa A, Kwan S. Preconception care for women with diabetes and prevention of major congenital malformations: Diabetes, Birth Defects, and Preconception Care. Birth Defects Research Part A: Clinical and Molecular Teratology 2010;88:791-803. [DOI: 10.1002/bdra.20734] [Cited by in Crossref: 55] [Cited by in F6Publishing: 66] [Article Influence: 4.2] [Reference Citation Analysis]
397 Chiu CJ, Taylor A. Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Prog Retin Eye Res 2011;30:18-53. [PMID: 20868767 DOI: 10.1016/j.preteyeres.2010.09.001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 102] [Article Influence: 7.5] [Reference Citation Analysis]
398 Kahrom M. An Innovative Mathematical Model: A Key to the Riddle of HbA(1c). Int J Endocrinol 2010;2010:481326. [PMID: 20871656 DOI: 10.1155/2010/481326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
399 Koga M, Murai J, Saito H, Mukai M, Toya D, Tanaka N, Kanehara H, Bando Y, Kasayama S. 1,5-Anhydroglucitol levels are low irrespective of plasma glucose levels in patients with chronic liver disease. Ann Clin Biochem. 2011;48:121-125. [PMID: 20736249 DOI: 10.1258/acb.2010.010053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
400 Ahola AJ, Mäkimattila S, Saraheimo M, Mikkilä V, Forsblom C, Freese R, Groop P; on behalf of the FinnDIANE Study Group. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately: Prandial insulin administration. Journal of Diabetes 2010;2:194-202. [DOI: 10.1111/j.1753-0407.2010.00086.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
401 Samtani MN. Simple pharmacometric tools for oral anti-diabetic drug development: competitive landscape for oral non-insulin therapies in type 2 diabetes. Biopharm Drug Dispos 2010;31:162-77. [PMID: 20213855 DOI: 10.1002/bdd.700] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
402 Tahara Y, Shima K. Evaluation of error levels in hemoglobin A1c and glycated albumin in type 2 diabetic patients due to inter-individual variability. Diabetes Research and Clinical Practice 2010;89:115-20. [DOI: 10.1016/j.diabres.2010.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
403 Khader S, Abdelfattah W, Almansari A, Elnnagar NK. Safety and efficacy of switching to biphasic insulin aspart 30/70 (BIAsp 30) under the routine diabetic care in patients with type 2 diabetes: The IMPROVE™ observational study in the Gulf region. International Journal of Diabetes Mellitus 2010;2:110-113. [DOI: 10.1016/j.ijdm.2010.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
404 Williams ME, Lacson E Jr, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses. Clin J Am Soc Nephrol 2010;5:1595-601. [PMID: 20671217 DOI: 10.2215/CJN.09301209] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 5.5] [Reference Citation Analysis]
405 Israel E, Geara A, Maarouf O, Ayoub I, Abi Rached J, Rizk S, Staynberg N, Samarneh M, El-Sayegh S. Correlation between glycated hemoglobin and mean plasma glucose in hemodialysis patients. Int Urol Nephrol 2011;43:1149-53. [PMID: 20658265 DOI: 10.1007/s11255-010-9800-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
406 Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study. Diabetes 2010;59:1585-90. [PMID: 20424232 DOI: 10.2337/db09-1774] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 5.1] [Reference Citation Analysis]
407 Strylewicz G, Doctor J. Evaluation of an automated method to assist with error detection in the ACCORD central laboratory. Clinical Trials 2010;7:380-9. [DOI: 10.1177/1740774510372779] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
408 Doctor JN, Strylewicz G. Detecting 'wrong blood in tube' errors: Evaluation of a Bayesian network approach. Artif Intell Med 2010;50:75-82. [PMID: 20566275 DOI: 10.1016/j.artmed.2010.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
409 Edge JA, James T, Shine B. Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years: Tracking of HbA1c levels in a children’s diabetes clinic. Diabetic Medicine 2010;27:1284-8. [DOI: 10.1111/j.1464-5491.2010.03057.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
410 Davenport MS, Cohan RH, Caoili EM, Ellis JH. Hyperglycemic Consequences of Corticosteroid Premedication in an Outpatient Population. American Journal of Roentgenology 2010;194:W483-8. [DOI: 10.2214/ajr.09.3906] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
411 Introduction. HbA1cin Diabetes 2010. [DOI: 10.1002/9781444320343.ch] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
412 Singh B, Saxena A. Surrogate markers of insulin resistance: A review. World J Diabetes 2010; 1(2): 36-47 [PMID: 21537426 DOI: 10.4239/wjd.v1.i2.36] [Cited by in CrossRef: 348] [Cited by in F6Publishing: 361] [Article Influence: 26.8] [Reference Citation Analysis]
413 Sarwat S, Ilag LL, Carey MA, Shrom DS, Heine RJ. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes: HbA 1c & SMBG in insulin-treated T2D. Diabetic Medicine 2010;27:589-92. [DOI: 10.1111/j.1464-5491.2010.02955.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
414 Young IS. Counterpoint: The Reporting of Estimated Glucose with Hemoglobin A1c. Clinical Chemistry 2010;56:547-9. [DOI: 10.1373/clinchem.2009.138677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
415 Sacks DB, Bergenstal RM, Mclaughlin S. Point: The Reporting of Estimated Glucose with Hemoglobin A1c. Clinical Chemistry 2010;56:545-6. [DOI: 10.1373/clinchem.2009.138669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
416 Segovia Portolés R, Ferrer-García JC, Merino-Torres JF, Penalba MT, Albalat Galera R, Piñón-Selles F. [Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control]. Endocrinol Nutr 2010;57:140-6. [PMID: 20347404 DOI: 10.1016/j.endonu.2010.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
417 Chen HS, Wu TE, Lin HD, Jap TS, Hsiao LC, Lee SH, Lin SH. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4. Am J Kidney Dis 2010;55:867-74. [PMID: 20202728 DOI: 10.1053/j.ajkd.2009.10.064] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
418 Mou S, Wang Q, Liu J, Che X, Zhang M, Cao L, Zhou W, Ni Z. Prevalence of non-diabetic renal disease in patients with type 2 diabetes. Diabetes Research and Clinical Practice 2010;87:354-9. [DOI: 10.1016/j.diabres.2009.11.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 4.3] [Reference Citation Analysis]
419 Vann MA. Perioperative management of ambulatory surgical patients with diabetes mellitus. Curr Opin Anaesthesiol 2009;22:718-24. [PMID: 19696663 DOI: 10.1097/ACO.0b013e3283310f51] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
420 Moitra VK, Greenberg J, Arunajadai S, Sweitzer B. The relationship between glycosylated hemoglobin and perioperative glucose control in patients with diabetes. Can J Anaesth 2010;57:322-9. [PMID: 20127531 DOI: 10.1007/s12630-010-9266-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
421 Escribano-serrano J, García-domínguez L, Díaz-pintado M. Glucohemoglobina. Tercera parte: interpretarla. SEMERGEN - Medicina de Familia 2010;36:95-9. [DOI: 10.1016/j.semerg.2009.11.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
422 Shrom D, Sarwat S, Ilag L, Bloomgarden ZT. Does A1c consistently reflect mean plasma glucose?: A1c versus mean plasma glucose. Journal of Diabetes 2010;2:92-6. [DOI: 10.1111/j.1753-0407.2010.00066.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
423 Neumiller JJ, Sclar DA, Robison LM, Maldonado AL, Setter SM, Skaer TL. Ethnicity/race and the extent of physician-ordered hemoglobin A1C during US office-based visits by patients with diabetes mellitus. Diabetes Educ 2010;36:65-6. [PMID: 20067945 DOI: 10.1177/0145721709358463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
424 van 't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010;33:61-6. [PMID: 19808928 DOI: 10.2337/dc09-0677] [Cited by in Crossref: 137] [Cited by in F6Publishing: 140] [Article Influence: 10.5] [Reference Citation Analysis]
425 American Diabetes Association. Standards of medical care in diabetes--2010. Diabetes Care 2010;33 Suppl 1:S11-61. [PMID: 20042772 DOI: 10.2337/dc10-S011] [Cited by in Crossref: 2115] [Cited by in F6Publishing: 2380] [Article Influence: 162.7] [Reference Citation Analysis]
426 Retnakaran R, Zinman B. Treatment of Type 1 Diabetes Mellitus in Adults. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00045-9] [Reference Citation Analysis]
427 Dungan KM, Buse JB. Management of Type 2 Diabetes Mellitus. Endocrinology 2010. [DOI: 10.1016/b978-1-4160-5583-9.00048-4] [Reference Citation Analysis]
428 Wong XW, Chase JG, E Hann C, F Lotz T, Lin J, Le Compte AJ, Shaw GM. In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes. J Diabetes Sci Technol 2008;2:436-49. [PMID: 19885208 DOI: 10.1177/193229680800200313] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
429 Randløv J, Poulsen JU. How much do forgotten insulin injections matter to hemoglobin a1c in people with diabetes? A simulation study. J Diabetes Sci Technol 2008;2:229-35. [PMID: 19885347 DOI: 10.1177/193229680800200209] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
430 Nielsen JK, Gravholt CH, Djurhuus CB, Brandt D, Becker J, Heinemann L, Christiansen JS. Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c. J Diabetes Sci Technol 2007;1:857-63. [PMID: 19885157 DOI: 10.1177/193229680700100609] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
431 Sacks DB. Correlation between hemoglobin A1c (HbA1c) and average blood glucose: can HbA1c be reported as estimated blood glucose concentration? J Diabetes Sci Technol 2007;1:801-3. [PMID: 19885151 DOI: 10.1177/193229680700100602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
432 Mattewal A, Aldasouqi S, Solomon D, Gossain V, Koller A. A1cNow InView: a new simple method for office-based glycohemoglobin measurement. J Diabetes Sci Technol 2007;1:879-84. [PMID: 19885160 DOI: 10.1177/193229680700100612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
433 Ceriello A. Hypothesis: the “metabolic memory”, the new challenge of diabetes. Diabetes Research and Clinical Practice 2009;86:S2-6. [DOI: 10.1016/s0168-8227(09)70002-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
434 Nauck MA, El-Ouaghlidi A, Vardarli I. Self-monitoring of blood glucose in diabetes mellitus: arguments for an individualized approach. Dtsch Arztebl Int 2009;106:587-94. [PMID: 19890425 DOI: 10.3238/arztebl.2009.0587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
435 Monnier L, Colette C. Target for glycemic control: concentrating on glucose. Diabetes Care 2009;32 Suppl 2:S199-204. [PMID: 19875552 DOI: 10.2337/dc09-S310] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
436 Siegelaar SE, Kilpatrick ES, Rigby AS, Atkin SL, Hoekstra JB, Devries JH. Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT. Diabetologia 2009;52:2229-32. [PMID: 19672575 DOI: 10.1007/s00125-009-1473-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
437 Gutschall MD, Miller CK, Mitchell DC, Lawrence FR. A randomized behavioural trial targeting glycaemic index improves dietary, weight and metabolic outcomes in patients with type 2 diabetes. Public Health Nutr 2009;12:1846-54. [DOI: 10.1017/s1368980008004680] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
438 Kilpatrick ES, Rigby AS, Atkin SL. The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol 2009;5:537-45. [PMID: 19763126 DOI: 10.1038/nrendo.2009.179] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
439 Turnacilar M, Sancar M, Apikoglu-Rabus S, Hursitoglu M, Izzettin FV. Improvement of diabetes indices of care by a short pharmaceutical care program. Pharm World Sci. 2009;31:689-695. [PMID: 19777365 DOI: 10.1007/s11096-009-9333-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
440 Bando Y, Kanehara H, Toya D, Tanaka N, Kasayama S, Koga M. Association of serum glycated albumin to haemoglobin A1C ratio with hepatic function tests in patients with chronic liver disease. Ann Clin Biochem 2009;46:368-72. [PMID: 19675058 DOI: 10.1258/acb.2009.008231] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
441 Knapp PE, Showers KM, Phipps JC, Speckman JL, Sternthal E, Freund KM, Ash AS, Apovian CM. Self-monitoring of blood glucose with finger tip versus alternative site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes. Diabetes Technol Ther 2009;11:219-25. [PMID: 19344196 DOI: 10.1089/dia.2008.0060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
442 Rentfro AR, McEwen M, Ritter L. Perspectives for practice: translating estimated average glucose (eAG) to promote diabetes self-management capacity. Diabetes Educ 2009;35:581, 585-6, 588-90 passim. [PMID: 19633165 DOI: 10.1177/0145721709338222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
443 Brick JC, Derr RL, Saudek CD. A Randomized Comparison of the Terms Estimated Average Glucose Versus Hemoglobin A1C. Diabetes Educ 2009;35:596-602. [DOI: 10.1177/0145721709336298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
444 Uzu T, Hatta T, Deji N, Izumiya T, Ueda H, Miyazawa I, Kanasaki M, Isshiki K, Nishio T, Arimura T. Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c). Ther Apher Dial 2009;13:89-94. [PMID: 19379146 DOI: 10.1111/j.1744-9987.2009.00661.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
445 Penttilä IM, Halonen T, Punnonen K, Tiikkainen U. Best use of the recommended IFCC reference method, material and values in HbA 1C analyses. Scandinavian Journal of Clinical and Laboratory Investigation 2009;65:453-62. [DOI: 10.1080/00365510510025809] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
446 Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, Frankel AH, Tam FW, Dornhorst A, Frost G, Turner JJ. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 2009;32:1137-42. [PMID: 19196889 DOI: 10.2337/dc08-1688] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
447 Graziano JA, Gross CR. A randomized controlled trial of an automated telephone intervention to improve glycemic control in type 2 diabetes. ANS Adv Nurs Sci 2009;32:E42-57. [PMID: 19707086 DOI: 10.1097/ANS.0b013e3181b117a9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
448 Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev 2009;25:393-402. [DOI: 10.1002/dmrr.962] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
449 Saudek CD, Brick JC. The clinical use of hemoglobin A1c. J Diabetes Sci Technol 2009;3:629-34. [PMID: 20144304 DOI: 10.1177/193229680900300402] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 4.9] [Reference Citation Analysis]
450 . Pancreas Gland Testing (Hypoglycemia and Diabetes). Endocrine and Metabolic Disorders 2009. [DOI: 10.1201/9781420079364.ch4] [Reference Citation Analysis]
451 Ametov AS, Karpova EV, Ivanova EV. Current state-of-the-art in the safe and efficient management of type 2 diabetes mellitusKey words: diabetes mellitus, vascular complications, glycemia control, management of diabetes mellitus. Diabetes mellitus 2009;12:18-24. [DOI: 10.14341/2072-0351-5392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
452 Diedrichs H, Pfister R, Clement Z, Hagemeister J, Schneider CA. Delta-glycated hemoglobin: a novel independent risk factor for cardiovascular events in patients without diabetes mellitus. J Endocrinol Invest 2009;32:564-7. [PMID: 19535894 DOI: 10.1007/BF03346509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
453 Day C, Bailey CJ. HbA 1c - changing units. Diabetes & Vascular Disease 2009;9:134-6. [DOI: 10.1177/1474651409106110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
454 Kleinclauss F, Fauda M, Sutherland DE, Kleinclauss C, Gruessner RW, Matas AJ, Kasiske BL, Humar A, Kandaswamy R, Kaul S. Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant. 2009;23:437-446. [PMID: 19496790 DOI: 10.1111/j.1399-0012.2009.00998.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 5.2] [Reference Citation Analysis]
455 Hill AN, Roche C, Appel SJ. Signs of improvement: Diabetes update 2009. The Nurse Practitioner 2009;34:12-22. [DOI: 10.1097/01.npr.0000352283.97228.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
456 Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 2009;26:115-21. [PMID: 19236612 DOI: 10.1111/j.1464-5491.2008.02652.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
457 Sikaris K. The correlation of hemoglobin A1c to blood glucose. J Diabetes Sci Technol 2009;3:429-38. [PMID: 20144279 DOI: 10.1177/193229680900300305] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
458 Albisser AM, Alejandro R, Sperlich M, Ricordi C. Prescription checking device promises to resolve intractable hypoglycemia. J Diabetes Sci Technol 2009;3:524-32. [PMID: 20144291 DOI: 10.1177/193229680900300317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
459 Albisser AM, Alejandro R, Sperlich M, Ricordi C. Closing the circle of care with new firmware for diabetes: MyDiaBase+RxChecker. J Diabetes Sci Technol 2009;3:619-23. [PMID: 20144302 DOI: 10.1177/193229680900300328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
460 Patiño-Fernández AM, Eidson M, Sanchez J, Delamater AM. What do Youth with Type 1 Diabetes Know about the HbA1c Test? Child Health Care 2010;38:157-67. [PMID: 20563233 DOI: 10.1080/02739610902813328] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
461 Góth L. Analytical problems in determination of hemoglobin A 1c and the different ways of its interpretation. Orvosi Hetilap 2009;150:747-51. [DOI: 10.1556/oh.2009.28603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
462 Brown JN, Kemp DW, Brice KR. Class Effect of Erythropoietin Therapy on Hemoglobin A 1c in a Patient with Diabetes Mellitus and Chronic Kidney Disease Not Undergoing Hemodialysis. Pharmacotherapy 2009;29:468-72. [DOI: 10.1592/phco.29.4.468] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
463 Little RR, Sacks DB. HbA1c: how do we measure it and what does it mean?: . Current Opinion in Endocrinology, Diabetes and Obesity 2009;16:113-8. [DOI: 10.1097/med.0b013e328327728d] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.4] [Reference Citation Analysis]
464 Sadat-Khonsari R, Dathe H, Knösel M, Hahn W, Kubein-Meesenburg D, Bauss O. Geometric influence of the sagittal and vertical apical base relationship on the ANB angle. J Orofac Orthop 2009;70:152-8. [PMID: 19322533 DOI: 10.1007/s00056-009-8809-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
465 Buxton OM, Malarick K, Wang W, Seeman T. Changes in dried blood spot Hb A1c with varied postcollection conditions. Clin Chem 2009;55:1034-6. [PMID: 19299546 DOI: 10.1373/clinchem.2008.111641] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
466 Haugaard SB, Madsbad S, Mølvig J. The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et al. Diabetologia 2009;52:547-9. [PMID: 19066843 DOI: 10.1007/s00125-008-1234-2] [Reference Citation Analysis]
467 Zaccardi F, Pitocco D, Ghirlanda G. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab Res Rev 2009;25:199-207. [DOI: 10.1002/dmrr.938] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.6] [Reference Citation Analysis]
468 Mealey BL. PATIENTS WITH DIABETES: Author's response. The Journal of the American Dental Association 2009;140:277-278. [DOI: 10.14219/jada.archive.2009.0145] [Reference Citation Analysis]
469 Faul JL, Wilson SR, Chu JW, Canfield J, Kuschner WG. The effect of an inhaled corticosteroid on glucose control in type 2 diabetes. Clin Med Res 2009;7:14-20. [PMID: 19251584 DOI: 10.3121/cmr.2009.824] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
470 Bleyer AJ, Hire D, Russell GB, Xu J, Divers J, Shihabi Z, Bowden DW, Freedman BI. Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin. Diabetic Medicine 2009;26:128-33. [DOI: 10.1111/j.1464-5491.2008.02646.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
471 Wu D, Zou C, Yue F, Li X, Li S, Zhang Y. The effect of long-term streptozotocin-induced diabetes mellitus (STZ-DM) on cynomolgus ( Macaca Fascicularis ) monkeys. Journal of Medical Primatology 2009;38:15-22. [DOI: 10.1111/j.1600-0684.2008.00300.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
472 Gallagher EJ, Le Roith D, Bloomgarden Z. Review of hemoglobin A1c in the management of diabetes: A1c in the management of diabetes. Journal of Diabetes 2009;1:9-17. [DOI: 10.1111/j.1753-0407.2009.00009.x] [Cited by in Crossref: 177] [Cited by in F6Publishing: 189] [Article Influence: 12.6] [Reference Citation Analysis]
473 Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW. Prevalence of diabetes and body burdens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p,p'-diphenyldichloroethene in Great Lakes sport fish consumers. Chemosphere 2009;75:674-9. [PMID: 19157498 DOI: 10.1016/j.chemosphere.2008.12.035] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 5.7] [Reference Citation Analysis]
474 Monnier L, Colette C. Targeting prandial hyperglycemia: how important is it and how best to do this? Curr Diab Rep 2008;8:368-74. [PMID: 18778585 DOI: 10.1007/s11892-008-0064-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
475 Paisooksantivatana K, Kongsomgan A, Leohirun L, Atamasirikul K, Kunakorn M. HemoglobinA1c level in healthy Thai adults: reference interval and fasting plasma glucose. Diabetes Res Clin Pract 2009;83:e43-6. [PMID: 19135277 DOI: 10.1016/j.diabres.2008.11.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
476 Go ET, Goggins W. Comparison of the glycemic control of the normo- and hypertensive Chinese patients with type 2 diabetes in a general outpatient clinic in Hong Kong. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2009;3:29-34. [DOI: 10.1016/j.dsx.2008.10.012] [Reference Citation Analysis]
477 Park S, Ko S, Lee S, Cho J, Moon S, Jang S, Song K, Son H, Yoon K, Cha B, Son H, Ahn Y. Average Daily Risk Range-Index of Glycemic Variability-Related Factor in Type 2 Diabetic Inpatients. Korean Diabetes J 2009;33:31. [DOI: 10.4093/kdj.2009.33.1.31] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
478 American Diabetes Association. Standards of medical care in diabetes--2009. Diabetes Care 2009;32 Suppl 1:S13-61. [PMID: 19118286 DOI: 10.2337/dc09-S013] [Cited by in Crossref: 1172] [Cited by in F6Publishing: 1322] [Article Influence: 83.7] [Reference Citation Analysis]
479 Streja DA. Optimizing diabetes management through glucose profiling: A case-based approach. Primary Care Diabetes 2008;2:167-73. [DOI: 10.1016/j.pcd.2008.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
480 Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Distribution and cardiovascular risk correlates of hemoglobin A(1c) in nondiabetic younger adults: the Bogalusa Heart Study. Metabolism 2008;57:1487-92. [PMID: 18940383 DOI: 10.1016/j.metabol.2008.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
481 Engoren M, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery. J Cardiothorac Surg 2008;3:63. [PMID: 19025628 DOI: 10.1186/1749-8090-3-63] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
482 Iqbal N, Morgan C, Maksoud H, Idris I. Improving patients' knowledge on the relationship between HbA1c and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes. Ann Clin Biochem 2008;45:504-7. [PMID: 18753424 DOI: 10.1258/acb.2008.008034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
483 Aldasouqi SA, Gossain VV. Hemoglobin A1c: past, present and future. Ann Saudi Med 2008;28:411-9. [PMID: 19011317 DOI: 10.5144/0256-4947.2008.411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
484 Sacks DB. Translating Hemoglobin A1c into Average Blood Glucose: Implications for Clinical Chemistry. Clinical Chemistry 2008;54:1756-8. [DOI: 10.1373/clinchem.2008.113282] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
485 Mealey BL. The interactions between physicians and dentists in managing the care of patients with diabetes mellitus. J Am Dent Assoc 2008;139 Suppl:4S-7S. [PMID: 18809648 DOI: 10.14219/jada.archive.2008.0362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
486 Monnier L, Colette C. Fasting glucose and postprandial glycemia: which is the best target for improving outcomes? The Apollo and 4-T Trials. Expert Opinion on Pharmacotherapy 2008;9:2857-65. [DOI: 10.1517/14656566.9.16.2857] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
487 Godbout A, Hammana I, Potvin S, Mainville D, Rakel A, Berthiaume Y, Chiasson JL, Coderre L, Rabasa-Lhoret R. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Diabetes Metab 2008;34:568-73. [PMID: 18922724 DOI: 10.1016/j.diabet.2008.05.010] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 3.5] [Reference Citation Analysis]
488 Macdonald DR, Hanson AM, Holland MR, Singh BM. Clinical impact of variability in HbA1c as assessed by simultaneously measuring fructosamine and use of error grid analysis. Ann Clin Biochem 2008;45:421-5. [PMID: 18583630 DOI: 10.1258/acb.2008.007259] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
489 Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA 1c as risk factors for Type 2 diabetes. Diabetic Medicine 2008;25:1157-63. [DOI: 10.1111/j.1464-5491.2008.02572.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
490 Han BG, Hao CM, Tchekneva EE, Wang YY, Lee CA, Ebrahim B, Harris RC, Kern TS, Wasserman DH, Breyer MD, Qi Z. Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. Am J Physiol Endocrinol Metab 2008;295:E981-6. [PMID: 18664598 DOI: 10.1152/ajpendo.90283.2008] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 3.8] [Reference Citation Analysis]
491 Robertson C. Translating ADA/EASD Guidelines and the ACE/AACE Road Maps into Primary Care of Patients with Type 2 Diabetes. The Journal for Nurse Practitioners 2008;4:661-71. [DOI: 10.1016/j.nurpra.2008.01.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
492 Miramontes Gonzlez J, Puerto Prez E, Martn Oterino J, Borao Cengoitiabengoa M. Hipoglucemia en pacientes diab?ticos tipo 2. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 2008;10:1204-1207. [DOI: 10.1016/s0211-3449(08)73228-4] [Reference Citation Analysis]
493 Monnier L, Colette C. La glycémie postprandiale : du normal au pathologique. Cahiers de Nutrition et de Diététique 2008;43:180-185. [DOI: 10.1016/s0007-9960(08)75436-1] [Reference Citation Analysis]
494 Khera PK, Joiner CH, Carruthers A, Lindsell CJ, Smith EP, Franco RS, Holmes YR, Cohen RM. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation. Diabetes 2008;57:2445-52. [PMID: 18591386 DOI: 10.2337/db07-1820] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 6.3] [Reference Citation Analysis]
495 Mast BT, Miles T, Penninx BW, Yaffe K, Rosano C, Satterfield S, Ayonayon HN, Harris T, Simonsick EM. Vascular disease and future risk of depressive symptomatology in older adults: findings from the Health, Aging, and Body Composition study. Biol Psychiatry 2008;64:320-6. [PMID: 18367153 DOI: 10.1016/j.biopsych.2008.01.025] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
496 Maia FFR, Araújo LR. A hipoglicemia silenciosa é parte do controle glicêmico ideal em pacientes com DM1? - tempo de hipoglicemia pelo CGMS versus média glicêmica. Arq Bras Endocrinol Metab 2008;52:994-1000. [DOI: 10.1590/s0004-27302008000600010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
497 Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-8. [PMID: 18540046 DOI: 10.2337/dc08-0545] [Cited by in Crossref: 1125] [Cited by in F6Publishing: 1148] [Article Influence: 75.0] [Reference Citation Analysis]
498 Kahn R, Fonseca V. Translating the A1C Assay. Diabetes Care 2008;31:1704-7. [PMID: 18540045 DOI: 10.2337/dc08-0878] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
499 Home PD. HbA 1c : the case for using estimated average glucose (eAG). Diabetic Medicine 2008;25:895-8. [DOI: 10.1111/j.1464-5491.2008.02516.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
500 Aydeniz A, Gursoy S, Guney E. Which musculoskeletal complications are most frequently seen in type 2 diabetes mellitus? J Int Med Res. 2008;36:505-511. [PMID: 18534132 DOI: 10.1177/147323000803600315] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 4.5] [Reference Citation Analysis]
501 Wajchenberg BL. Postprandial glycemia and cardiovascular disease in diabetes mellitus. Arq Bras Endocrinol Metabol 2007;51:212-21. [PMID: 17505628 DOI: 10.1590/s0004-27302007000200010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
502 Moiz B, Hashmi MR, Sadaf S. Performance evaluation of ion exchange and affinity chromatography for HbA1c estimation in diabetic patients with HbD: a study of 129 samples. Clin Biochem. 2008;41:1204-1210. [PMID: 18644359 DOI: 10.1016/j.clinbiochem.2008.06.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
503 Bloomgarden ZT, Inzucchi SE, Karnieli E, Le Roith D. The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted. Diabetologia 2008;51:1111-4. [PMID: 18449525 DOI: 10.1007/s00125-008-1027-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
504 Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-53. [PMID: 18460560 DOI: 10.1210/jc.2007-2174] [Cited by in Crossref: 290] [Cited by in F6Publishing: 306] [Article Influence: 19.3] [Reference Citation Analysis]
505 Maki K, Curry L, Reeves M, Toth P, Mckenney J, Farmer M, Schwartz S, Lubin B, Boileau A, Dicklin M, Carakostas M, Tarka S. Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus. Food and Chemical Toxicology 2008;46:S47-53. [DOI: 10.1016/j.fct.2008.05.007] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 6.1] [Reference Citation Analysis]
506 Sassa M, Yamada Y, Hosokawa M, Fukuda K, Fujimoto S, Toyoda K, Tsukiyama K, Seino Y, Inagaki N. Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes. Diabetes Res Clin Pract. 2008;81:190-195. [PMID: 18514964 DOI: 10.1016/j.diabres.2008.04.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
507 Koga M, Kasayama S, Kanehara H, Bando Y. CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract 2008;81:258-62. [PMID: 18513821 DOI: 10.1016/j.diabres.2008.04.012] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 4.1] [Reference Citation Analysis]
508 Mazze R. The Future of Self-Monitored Blood Glucose: Mean Blood Glucose Versus Glycosylated Hemoglobin. Diabetes Technology & Therapeutics 2008;10:S-93-S-101. [DOI: 10.1089/dia.2008.0006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
509 Cruzes AL, Bosco CET, Pandini EV, Hernandez MAM, Silva RCQD. Hiperglicemia pós-prandial em pacientes com diabetes melito tipo 2. Arq Bras Endocrinol Metab 2008;52:642-648. [DOI: 10.1590/s0004-27302008000400010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
510 Block JL, Shanks A, Morris M, Turner CR. Incidence of preoperative hyperglycemia. J Clin Anesth 2008;20:239-41. [PMID: 18502375 DOI: 10.1016/j.jclinane.2008.01.003] [Reference Citation Analysis]
511 Nanda S, Sharma SG, Bhatt SP, Pamula J, Arastu MI. Conundrum of elevated HbA1C and hypoglycemia-a rare cause. Am J Med Sci 2008;335:382-6. [PMID: 18480656 DOI: 10.1097/MAJ.0b013e3181461679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
512 Pagenkemper JJ. Diabetes Mellitus. Nutrition and Health. [DOI: 10.1007/978-1-59745-032-4_6] [Reference Citation Analysis]
513 Geist SRY, Geist JR. Improvement in Medical Consultation Responses with a Structured Request Form. Journal of Dental Education 2008;72:553-61. [DOI: 10.1002/j.0022-0337.2008.72.5.tb04519.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
514 Gandhi R, Brown J, Simm A, Page R, Idris I. HbA1c during pregnancy: Its relationship to meal related glycaemia and neonatal birth weight in patients with diabetes. European Journal of Obstetrics & Gynecology and Reproductive Biology 2008;138:45-8. [DOI: 10.1016/j.ejogrb.2007.08.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
515 Demmer RT, Kocher T, Schwahn C, Völzke H, Jacobs DR Jr, Desvarieux M. Refining exposure definitions for studies of periodontal disease and systemic disease associations. Community Dent Oral Epidemiol 2008;36:493-502. [PMID: 18422705 DOI: 10.1111/j.1600-0528.2008.00435.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
516 Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients. Diabet Med 2008;25:174-8. [PMID: 18290858 DOI: 10.1111/j.1464-5491.2007.02379.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
517 Hamrén B, Björk E, Sunzel M, Karlsson M. Models for Plasma Glucose, HbA1c, and Hemoglobin Interrelationships in Patients with Type 2 Diabetes Following Tesaglitazar Treatment. Clin Pharmacol Ther 2008;84:228-35. [DOI: 10.1038/clpt.2008.2] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
518 Wilson DM, Kollman; Diabetes Research in Children Network (DirecNet) Study Group. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care 2008;31:381-5. [PMID: 18056888 DOI: 10.2337/dc07-1835] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 6.5] [Reference Citation Analysis]
519 Sáez de la Fuente J, Granja Berna V, Ferrari Piquero JM, Valero Zanuy MA, Herreros de Tejada López-Coterilla A. [Types of insulin therapy]. Rev Clin Esp 2008;208:76-86. [PMID: 18261394 DOI: 10.1157/13115203] [Reference Citation Analysis]
520 Pupillo M, De Berardis G, Antenucci D, Minnucci A, Nicolucci A. Glycated haemoglobin or mean blood glucose as indicators of metabolic control in Type 2 diabetes? Diabetes Res Clin Pract 2008;80:e1-3. [PMID: 18258329 DOI: 10.1016/j.diabres.2008.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
521 Diedrichs H, Pfister R, Hagemeister J, Müller-ehmsen J, Frank KF, Höpp H, Erdmann E, Schneider CA. An increase in HbA 1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitus. Diabetic Med 2008;25:228-31. [DOI: 10.1111/j.1464-5491.2007.02320.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
522 Kilpatrick ES, Rigby AS, Atkin SL. Mean blood glucose compared with HbA1c in the prediction of cardiovascular disease in patients with type 1 diabetes. Diabetologia 2008;51:365-71. [PMID: 18040661 DOI: 10.1007/s00125-007-0883-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
523 Manley SE. Estimated average glucose derived from HbA 1c (eAG): report from European Association for the Study of Diabetes (EASD), Amsterdam 2007. Diabetic Med 2008;25:126-8. [DOI: 10.1111/j.1464-5491.2008.02383.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
524 Liu L, Hood S, Wang Y, Bezverkov R, Dou C, Datta A, Yuan C. Direct enzymatic assay for %HbA1c in human whole blood samples. Clin Biochem 2008;41:576-83. [PMID: 18261468 DOI: 10.1016/j.clinbiochem.2008.01.013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.8] [Reference Citation Analysis]
525 Ceriello A. La “memoria metabólica” inducida por la hiperglucemia: el nuevo reto en la prevención de la enfermedad cardiovascular en la diabetes. Revista Española de Cardiología Suplementos 2008;8:12C-18C. [DOI: 10.1016/s1131-3587(08)73550-7] [Reference Citation Analysis]
526 Giugliano D, Ceriello A, Esposito K. Glucose metabolism and hyperglycemia. Am J Clin Nutr 2008;87:217S-22S. [PMID: 18175761 DOI: 10.1093/ajcn/87.1.217S] [Cited by in Crossref: 135] [Cited by in F6Publishing: 135] [Article Influence: 9.0] [Reference Citation Analysis]
527 Bode BW. Incorporating postprandial and fasting plasma glucose into clinical management strategies. Insulin 2008;3:17-27. [DOI: 10.1016/s1557-0843(08)80006-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
528 Wong X, Chase JG, Le Compte AJ, Hann CE, Lin J, Shaw GM. An adaptive clinical Type 1 diabetes control protocol to optimize conventional self-monitoring blood glucose and multiple daily-injection therapy. Int J Adapt Control Signal Process 2008. [DOI: 10.1002/acs.1069] [Reference Citation Analysis]
529 Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol. 2007;34:835-843. [PMID: 17850602 DOI: 10.1111/j.1600-051x.2007.01127.x] [Cited by in Crossref: 119] [Cited by in F6Publishing: 124] [Article Influence: 7.4] [Reference Citation Analysis]
530 Ahmad Khan H. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta Diabetol 2007;44:193-200. [PMID: 17786383 DOI: 10.1007/s00592-007-0003-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
531 Kilpatrick ES, Rigby AS, Goode K, Atkin SL. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes. Diabetologia 2007;50:2553-61. [PMID: 17882397 DOI: 10.1007/s00125-007-0820-z] [Cited by in Crossref: 171] [Cited by in F6Publishing: 135] [Article Influence: 10.7] [Reference Citation Analysis]
532 Russell-Jones DL. Insulin detemir and basal insulin therapy. Endocrinol Metab Clin North Am 2007;36 Suppl 1:7-13. [PMID: 17881327 DOI: 10.1016/s0889-8529(07)80003-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
533 Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007;50:2239-44. [PMID: 17851648 DOI: 10.1007/s00125-007-0803-0] [Cited by in Crossref: 286] [Cited by in F6Publishing: 252] [Article Influence: 17.9] [Reference Citation Analysis]
534 American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007;50:2042-3. [PMID: 17712546 DOI: 10.1007/s00125-007-0789-7] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 6.1] [Reference Citation Analysis]
535 Roszyk L, Faye B, Sapin V, Somda F, Tauveron I. Glycated haemoglobin (HbA1c): today and tomorrow. Ann Endocrinol (Paris) 2007;68:357-65. [PMID: 17904515 DOI: 10.1016/j.ando.2007.06.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
536 Wang Y, Beckwith B, Smith C, Horowitz G. Misleading glycated hemoglobin results in a patient with hemoglobin SC disease. Clin Chem 2007;53:1394-5. [PMID: 17582158 DOI: 10.1373/clinchem.2006.082917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
537 Service FJ, O’Brien PC. Influence of glycemic variables on hemoglobin A1c. Endocr Pract. 2007;13:350-354. [PMID: 17669710 DOI: 10.4158/ep.13.4.350] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
538 Consensus Committee. Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 2007;30:2399-400. [PMID: 17726190 DOI: 10.2337/dc07-9925] [Cited by in Crossref: 225] [Cited by in F6Publishing: 232] [Article Influence: 14.1] [Reference Citation Analysis]
539 Al-Lawati JA, Al-Lawati AM. The utility of fasting plasma glucose in predicting glycosylated hemoglobin in type 2 diabetes. Ann Saudi Med 2007;27:347-51. [PMID: 17921686 DOI: 10.5144/0256-4947.2007.347] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
540 Boizel R, Benhamou PY, Renard E; Accu-Chek Pocket Compass Study Group. Glucose monitoring and pump data management software operated on a personal digital assistant can contribute to improve diabetes control in CSII-treated patients. Diabetes Metab 2007;33:314-5. [PMID: 17475533 DOI: 10.1016/j.diabet.2007.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
541 Gordin D, Rönnback M, Forsblom C, Heikkilä O, Saraheimo M, Groop PH. Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia 2007;50:1808-14. [PMID: 17611734 DOI: 10.1007/s00125-007-0730-0] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
542 Albarracin C, Fuqua B, Geohas J, Juturu V, Finch MR, Komorowski JR. Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial. J Cardiometab Syndr 2007;2:91-7. [PMID: 17684468 DOI: 10.1111/j.1559-4564.2007.06366.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
543 Deb-Joardar N, Germain N, Thuret G, Garcin A-, Manoli P, Defreyn A, Gain P, Estour B. Systematic screening for diabetic retinopathy with a digital fundus camera following pupillary dilatation in a university diabetes department. Diabet Med 2007;24:303-7. [PMID: 17263768 DOI: 10.1111/j.1464-5491.2006.02030.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
544 Bruns DE. The Clinical Chemist. Clinical Chemistry 2007;53:1562-4. [DOI: 10.1373/clinchem.2007.094078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
545 Langley AK, Suffoletta TJ, Jennings HR. Dipeptidyl Peptidase IV Inhibitors and the Incretin System in Type 2 Diabetes Mellitus. Pharmacotherapy 2007;27:1163-80. [DOI: 10.1592/phco.27.8.1163] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
546 Ceriello A. Post-Prandial Endothelial Dysfunction, Oxidative Stress, and Inflammation in Type 2 Diabetes. Oxidative Stress and Disease 2007. [DOI: 10.1201/9781420043792.ch8] [Reference Citation Analysis]
547 Gardner D, Khan K, Govindarajan G, Palmer J, Sowers J. Type 1 Diabetes Mellitus. Comprehensive Management of High Risk Cardiovascular Patients 2007. [DOI: 10.3109/9781420019667-6] [Reference Citation Analysis]
548 Grunfeld C, Thompson M, Brown SJ, Richmond G, Lee D, Muurahainen N, Kotler DP. Recombinant Human Growth Hormone to Treat HIV-Associated Adipose Redistribution Syndrome: 12-Week Induction and 24-Week Maintenance Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 2007;45:286-97. [DOI: 10.1097/qai.0b013e31804a7f68] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.2] [Reference Citation Analysis]
549 Wahba H, Chang Y. Factors Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus in Rural Areas of the United States. Insulin 2007;2:134-141. [DOI: 10.1016/s1557-0843(07)80042-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
550 Mealey BL, Ocampo GL. Diabetes mellitus and periodontal disease. Periodontol 2000. 2007;44:127-153. [PMID: 17474930 DOI: 10.1111/j.1600-0757.2006.00193.x] [Cited by in Crossref: 272] [Cited by in F6Publishing: 299] [Article Influence: 17.0] [Reference Citation Analysis]
551 Lund SS, Tarnow L, Stehouwer CD, Schalkwijk CG, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag A. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab. 2007;9:394-407. [PMID: 17391168 DOI: 10.1111/j.1463-1326.2007.00713.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
552 Baum K, Votteler T, Schiab J. Efficiency of vibration exercise for glycemic control in type 2 diabetes patients. Int J Med Sci 2007;4:159-63. [PMID: 17554399 DOI: 10.7150/ijms.4.159] [Cited by in Crossref: 40] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
553 Shultis WA, Leary SD, Ness AR, Scott J, Martin RM, Whincup PH, Smith GD; ALSPAC Study Team. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC). Diabet Med 2006;23:1357-63. [PMID: 17116188 DOI: 10.1111/j.1464-5491.2006.01990.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
554 Ihnat MA, Thorpe JE, Ceriello A. Hypothesis: the ‘metabolic memory’, the new challenge of diabetes. Diabet Med. 2007;24:582-586. [PMID: 17490424 DOI: 10.1111/j.1464-5491.2007.02138.x] [Cited by in Crossref: 122] [Cited by in F6Publishing: 127] [Article Influence: 7.6] [Reference Citation Analysis]
555 Edelman S, Dailey G, Flood T, Kuritzky L, Renda S. A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes. Osteopath Med Prim Care 2007;1:9. [PMID: 17448241 DOI: 10.1186/1750-4732-1-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
556 Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med. 2006;23:944-954. [PMID: 16922700 DOI: 10.1111/j.1464-5491.2006.01906.x] [Cited by in Crossref: 221] [Cited by in F6Publishing: 241] [Article Influence: 13.8] [Reference Citation Analysis]
557 Schneider HG, Goodall I, Colman PG, McLean M, Barker G; Australian Working Party for HbA1c standardization. New haemoglobin A1c: the way it is reported is about to change... Intern Med J 2007;37:213-5. [PMID: 17388859 DOI: 10.1111/j.1445-5994.2006.01302.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
558 Schrot RJ, Patel KT, Foulis P. Evaluation of Inaccuracies in the Measurement of Glycemia in the Laboratory, by Glucose Meters, and Through Measurement of Hemoglobin A1c. Clinical Diabetes 2007;25:43-49. [DOI: 10.2337/diaclin.25.2.43] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.7] [Reference Citation Analysis]
559 Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M. A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available. Diabet Med 2006;23:1151-4. [PMID: 16978383 DOI: 10.1111/j.1464-5491.2006.01927.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
560 Kilpatrick ES, Rigby AS, Atkin SL. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem 2007;53:897-901. [PMID: 17384010 DOI: 10.1373/clinchem.2006.079756] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 4.4] [Reference Citation Analysis]
561 Boysen G, Georgieva NI, Upton PB, Walker VE, Swenberg JA. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides. Chemico-Biological Interactions 2007;166:84-92. [DOI: 10.1016/j.cbi.2006.10.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
562 Nissimov J, Elchalal U, Bakala H, Brownlee M, Berry E, Phillip M, Milner Y. Method for chronological recording of antigen appearance in human head-hair shafts and its use for monitoring glycation products in diabetes. Journal of Immunological Methods 2007;320:1-17. [DOI: 10.1016/j.jim.2006.10.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
563 Kohnert KD, Augstein P, Heinke P, Zander E, Peterson K, Freyse EJ, Salzsieder E. Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract. 2007;77:420-426. [PMID: 17331614 DOI: 10.1016/j.diabres.2007.01.021] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 3.1] [Reference Citation Analysis]
564 Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review. Diabetes Technol Ther. 2006;8:677-687. [PMID: 17109600 DOI: 10.1089/dia.2006.8.677] [Cited by in Crossref: 125] [Cited by in F6Publishing: 128] [Article Influence: 7.8] [Reference Citation Analysis]
565 Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc 2007;82:229-35; quiz 236. [PMID: 17290732 DOI: 10.4065/82.2.229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 0.4] [Reference Citation Analysis]
566 Stickle DF, Seligman ML, Landmark JD, Quon MJ. Predicted effects of hemoglobin A1c assay precision on a patient population distribution of serial hemoglobin A1c difference values. Clin Chim Acta 2007;378:201-5. [PMID: 17229418 DOI: 10.1016/j.cca.2006.11.022] [Reference Citation Analysis]
567 American Diabetes Association. Standards of medical care in diabetes--2007. Diabetes Care 2007;30 Suppl 1:S4-S41. [PMID: 17192377 DOI: 10.2337/dc07-S004] [Cited by in Crossref: 1033] [Cited by in F6Publishing: 1147] [Article Influence: 64.6] [Reference Citation Analysis]
568 Moon JW, Song SJ, Koo BK, Cho YM, Yu HG. Short-term Effects and Side Effects of Tacrolimus for Behçet's Uveitis. J Korean Ophthalmol Soc 2007;48:1654. [DOI: 10.3341/jkos.2007.48.12.1654] [Reference Citation Analysis]
569 Osterman-Golkar SM, Vesper HW. Assessment of the relationship between glucose and A1c using kinetic modeling. J Diabetes Complications 2006;20:285-94. [PMID: 16949515 DOI: 10.1016/j.jdiacomp.2005.07.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
570 Van Zyl D. Optimal glucose control in type 2 diabetes mellitus—a guide for the family practitioner. South African Family Practice 2006;48:22-29. [DOI: 10.1080/20786204.2006.10873481] [Reference Citation Analysis]
571 Robertson D. Achieving fasting and postprandial blood glucose control in type 2 diabetes. Br J Hosp Med (Lond) 2006;67:518-22. [PMID: 17069120 DOI: 10.12968/hmed.2006.67.10.22057] [Reference Citation Analysis]
572 Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, Dominguez LJ, Barbagallo M. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 2006;25:210-5. [PMID: 16766779 DOI: 10.1080/07315724.2006.10719534] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]
573 Rendell MS, Jovanovic L. Targeting postprandial hyperglycemia. Metabolism 2006;55:1263-81. [PMID: 16919548 DOI: 10.1016/j.metabol.2006.05.012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 3.1] [Reference Citation Analysis]
574 Smellie WS, Forth J, Bareford D, Twomey P, Galloway MJ, Logan EC, Smart SR, Reynolds TM, Waine C. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9. [PMID: 16873560 DOI: 10.1136/jcp.200X.033944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 27] [Article Influence: 1.1] [Reference Citation Analysis]
575 Gardner DW, Khan KA, Govindarajan G, Palmer JM, Sowers JR. Type 1 Diabetes Mellitus. Comprehensive Management of High Risk Cardiovascular Patients 2006. [DOI: 10.3109/9781420019667.005] [Reference Citation Analysis]
576 Dailey GE. Contributions of fasting and postprandial plasma glucose levels to glycosylated hemoglobin and diabetes mellitus-related complications: Treating hyperglycemia with insulin. Insulin 2006;1:148-157. [DOI: 10.1016/s1557-0843(06)80035-7] [Reference Citation Analysis]
577 Stene LC, Barriga K, Hoffman M, Kean J, Klingensmith G, Norris JM, Erlich HA, Eisenbarth GS, Rewers M. Normal but increasing hemoglobin A1c levels predict progression from islet autoimmunity to overt type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). Pediatr Diabetes 2006;7:247-53. [PMID: 17054445 DOI: 10.1111/j.1399-5448.2006.00198.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]
578 Williams M, Lacson E, Teng M, Ofsthun N, Lazarus J. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney International 2006;70:1503-9. [DOI: 10.1038/sj.ki.5001789] [Cited by in Crossref: 144] [Cited by in F6Publishing: 145] [Article Influence: 8.5] [Reference Citation Analysis]
579 Reynolds TM, Smellie WS, Twomey PJ. Glycated haemoglobin (HbA1c) monitoring. BMJ 2006;333:586-8. [PMID: 16974013 DOI: 10.1136/bmj.38947.627847.AE] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
580 Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77:1289-1303. [PMID: 16881798 DOI: 10.1902/jop.2006.050459] [Cited by in Crossref: 511] [Cited by in F6Publishing: 555] [Article Influence: 30.1] [Reference Citation Analysis]
581 Monnier L, Colette C, Boniface H. Contribution of postprandial glucose to chronic hyperglycaemia: from the “glucose triad” to the trilogy of “sevens”. Diabetes & Metabolism 2006;32:2S11-6. [DOI: 10.1016/s1262-3636(06)70479-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
582 Greenberg PD, Rosman AS, Eldeiry LS, Naqvi Z, Bräu N. Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. J Viral Hepat 2006;13:613-7. [PMID: 16907848 DOI: 10.1111/j.1365-2893.2006.00729.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
583 Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med 2006;260:263-71. [PMID: 16918824 DOI: 10.1111/j.1365-2796.2006.01689.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 3.4] [Reference Citation Analysis]
584 Boutayeb A, Chetouani A. A critical review of mathematical models and data used in diabetology. Biomed Eng Online 2006;5:43. [PMID: 16808835 DOI: 10.1186/1475-925X-5-43] [Cited by in Crossref: 77] [Cited by in F6Publishing: 75] [Article Influence: 4.5] [Reference Citation Analysis]
585 Kvapil M, Svatko A, Khilberg K, Shestakova MV. Dvukhfaznyy insulin aspart 30 plyusmetformin: effektivnaya kombinatsiyadlya lecheniya sakharnogo diabeta 2 tipa. Diabetes mellitus 2006;9:50-59. [DOI: 10.14341/2072-0351-6119] [Reference Citation Analysis]
586 Wangnoo S, Siddiqui A, Tarunika, Chaturvedi R. The Role of Self Monitoring of Blood Glucose in People with Diabetes. Apollo Medicine 2006;3:231-234. [DOI: 10.1016/s0976-0016(11)60203-2] [Reference Citation Analysis]
587 Kvapil M, Swatko A, Hilberg C, Shestakova M. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes. Diabetes Obes Metab 2006;8:39-48. [PMID: 16367881 DOI: 10.1111/j.1463-1326.2005.00492.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 2.1] [Reference Citation Analysis]
588 Kaholokula JK, Haynes SN, Grandinetti A, Chang HK. Ethnic differences in the relationship between depressive symptoms and health-related quality of life in people with type 2 diabetes. Ethn Health 2006;11:59-80. [PMID: 16338755 DOI: 10.1080/13557850500391287] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
589 Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006;74:33-40. [PMID: 16621108 DOI: 10.1016/j.diabres.2006.03.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 2.6] [Reference Citation Analysis]
590 Rizvi AA, Sanders MB. Assessment and monitoring of glycemic control in primary diabetes care: monitoring techniques, record keeping, meter downloads, tests of average glycemia, and point-of-care evaluation. J Am Acad Nurse Pract 2006;18:11-21. [PMID: 16403208 DOI: 10.1111/j.1745-7599.2006.00092.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
591 Mosca A, Paleari R, Dalfrà MG, Di Cianni G, Cuccuru I, Pellegrini G, Malloggi L, Bonomo M, Granata S, Ceriotti F, Castiglioni MT, Songini M, Tocco G, Masin M, Plebani M, Lapolla A. Reference intervals for hemoglobin A1c in pregnant women: data from an Italian multicenter study. Clin Chem 2006;52:1138-43. [PMID: 16601066 DOI: 10.1373/clinchem.2005.064899] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 5.9] [Reference Citation Analysis]
592 Sassa M, Fukuda K, Fujimoto S, Toyoda K, Fujita Y, Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, Ohara T, Okamoto M, Tanaka K, Seino Y, Inagaki N, Yamada Y. A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement. Diabetes Res Clin Pract 2006;73:235-40. [PMID: 16600414 DOI: 10.1016/j.diabres.2006.01.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
593 Davies MJ. LETTERS. Diabet Med 2006;23:25-6. [DOI: 10.1111/j.1464-5491.2006.01833h.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
594 Aulesa C, Potau N. Estandarización de la glicohemoglobina. Unificación de resultados y nueva terminología. Endocrinología y Nutrición 2006;53:197-8. [DOI: 10.1016/s1575-0922(06)71089-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
595 Alam T, Weintraub N, Weinreb J. What Is the Proper Use of Hemoglobin A1c Monitoring in the Elderly? Journal of the American Medical Directors Association 2006;7:S60-4. [DOI: 10.1016/j.jamda.2005.12.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
596 Hassan Y, Johnson B, Nader N, Gannon MC, Nuttall FQ. The relationship between 24-hour integrated glucose concentrations and % glycohemoglobin. J Lab Clin Med 2006;147:21-6. [PMID: 16443001 DOI: 10.1016/j.lab.2005.05.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
597 Port SC, Boyle NG, Hsueh WA, Quiñones MJ, Jennrich RI, Goodarzi MO. The predictive role of blood glucose for mortality in subjects with cardiovascular disease. Am J Epidemiol 2006;163:342-51. [PMID: 16373527 DOI: 10.1093/aje/kwj027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
598 Woodward G, van Walraven C, Hux JE. Utilization and outcomes of HbA1c testing: a population-based study. CMAJ 2006;174:327-9. [PMID: 16446473 DOI: 10.1503/cmaj.1031433] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
599 LeRoith D, Smith DO. Monitoring glycemic control: the cornerstone of diabetes care. Clin Ther. 2005;27:1489-1499. [PMID: 16330287 DOI: 10.1016/j.clinthera.2005.10.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
600 Jovanovic L, Nakai Y. Successful pregnancy in women with type 1 diabetes: from preconception through postpartum care. Endocrinol Metab Clin North Am 2006;35:79-97, vi. [PMID: 16310643 DOI: 10.1016/j.ecl.2005.09.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
601 American Diabetes Association. Standards of Medical Care in Diabetes–2006. Diabetes Care 2006;29:s4-s42. [DOI: 10.2337/diacare.29.s1.06.s4] [Cited by in Crossref: 311] [Cited by in F6Publishing: 285] [Article Influence: 18.3] [Reference Citation Analysis]
602 Kennedy L, Herman WH, Strange P, Harris A; GOAL AIC Team. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006;29:1-8. [PMID: 16373887 DOI: 10.2337/diacare.29.01.06.dc05-1058] [Cited by in Crossref: 130] [Cited by in F6Publishing: 131] [Article Influence: 7.6] [Reference Citation Analysis]
603 Gorus F, Mathieu C, Gerlo E. How should HbA1c measurements be reported? Diabetologia 2006;49:7-10. [PMID: 16378164 DOI: 10.1007/s00125-005-0073-7] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
604 Mooradian AD. Diabetes as a Model of Premature Aging. Handbook of Models for Human Aging 2006. [DOI: 10.1016/b978-012369391-4/50057-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
605 Monnier L, Colette C. Contributions of Fasting and Postprandial Glucose to Hemoglobin A1c. Endocrine Practice 2006;12:42-6. [DOI: 10.4158/ep.12.s1.42] [Cited by in Crossref: 91] [Cited by in F6Publishing: 96] [Article Influence: 5.4] [Reference Citation Analysis]
606 Albisser AM, Alejandro R, Meneghini LF, Ricordi C. How Good Is Your Glucose Control? Diabetes Technology & Therapeutics 2005;7:863-75. [DOI: 10.1089/dia.2005.7.863] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
607 Chalew SA, McCarter RJ, Thomas J, Thomson JL, Hempe JM. A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes. J Diabetes Complications. 2005;19:218-222. [PMID: 15993356 DOI: 10.1016/j.jdiacomp.2005.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
608 Doruk H, Mas MR, Ateşkan U, Isik AT, Sağlam M, Kutlu M. The relationship between age and carotid artery intima-media thickness, hemoglobin A1c in nondiabetic, healthy geriatric population. Arch Gerontol Geriatr 2005;41:113-9. [PMID: 16085062 DOI: 10.1016/j.archger.2004.11.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
609 Mesa J, Salcedo D, Calle Hde L, Delgado E, Nóvoa J, Hawkins F, Navarrete GS, Parramón M, Acosta D. Detection of ketonemia and its relationship with hyperglycemia in type 1 diabetic patients. Diabetes Res Clin Pract 2006;72:292-7. [PMID: 16297489 DOI: 10.1016/j.diabres.2005.10.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
610 del Cañizo-gómez F, Moreira-andrés M. Glucemia posprandial y riesgo cardiovascular. Endocrinología y Nutrición 2005;52:452-465. [DOI: 10.1016/s1575-0922(05)71043-3] [Reference Citation Analysis]
611 Brennan AL, Gyi KM, Wood DM, Hodson ME, Geddes DM, Baker EH. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. J Cyst Fibros. 2006;5:27-31. [PMID: 16202666 DOI: 10.1016/j.jcf.2005.09.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
612 Markolf H, Frank S. Prandial hyperglycemia: Is it important to track and treat? Curr Diab Rep 2005;5:333-9. [DOI: 10.1007/s11892-005-0090-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
613 Gerich JE. The importance of tight glycemic control. Am J Med 2005;118:7S-11S. [PMID: 16224937 DOI: 10.1016/j.amjmed.2005.07.051] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
614 Renard E. Monitoring glycemic control: the importance of self-monitoring of blood glucose. Am J Med 2005;118:12S-9S. [PMID: 16224938 DOI: 10.1016/j.amjmed.2005.07.052] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
615 Kosecki SM, Rodgers PT, Adams MB. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy. Ann Pharmacother 2005;39:1557-60. [PMID: 16076916 DOI: 10.1345/aph.1G010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
616 Bouhours-nouet N, Coutant R. Clinique et diagnostic du diabète de l'enfant. EMC - Pédiatrie 2005;2:220-242. [DOI: 10.1016/j.emcped.2005.06.001] [Reference Citation Analysis]
617 Buse JB, Rubin CJ, Frederich R, Viraswami-appanna K, Lin K, Montoro R, Shockey G, Davidson JA. Muraglitazar, a dual (α/γ) PPAR activator: A randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes. Clinical Therapeutics 2005;27:1181-95. [DOI: 10.1016/j.clinthera.2005.08.005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
618 Frid AH, Nilsson M, Holst JJ, Björck IM. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. The American Journal of Clinical Nutrition 2005;82:69-75. [DOI: 10.1093/ajcn/82.1.69] [Cited by in Crossref: 260] [Cited by in F6Publishing: 262] [Article Influence: 14.4] [Reference Citation Analysis]
619 Fiallo-Scharer R; Diabetes Research in Children Network Study Group. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycemic control in type 1 diabetes. J Clin Endocrinol Metab 2005;90:3387-91. [PMID: 15784705 DOI: 10.1210/jc.2004-2510] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 3.7] [Reference Citation Analysis]
620 Alam T, Weintraub N, Weinreb J. What Is the Proper Use of Hemoglobin A1c Monitoring in the Elderly? Journal of the American Medical Directors Association 2005;6:200-4. [DOI: 10.1016/j.jamda.2005.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
621 Monnier L, Benichou M, Charra-ebrard S, Boegner C, Colette C. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives. Diabetes & Metabolism 2005;31:101-9. [DOI: 10.1016/s1262-3636(07)70174-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
622 Campos-delgado DU, Femat R, Hernández-ordoñez M, Gordillo-moscoso A. Self-tuning insulin adjustment algorithm for type 1 diabetic patients based on multi-doses regime. Applied Bionics and Biomechanics 2005;2:61-71. [DOI: 10.1533/abbi.2004.0031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
623 Rodríguez-Segade S, Rodríguez J, Mayan D, Camiña F. Plasma albumin concentration is a predictor of HbA1c among type 2 diabetic patients, independently of fasting plasma glucose and fructosamine. Diabetes Care 2005;28:437-9. [PMID: 15677811 DOI: 10.2337/diacare.28.2.437] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
624 Szwergold BS. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines. Medical Hypotheses 2005;65:337-48. [DOI: 10.1016/j.mehy.2005.02.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
625 Dailey G. New strategies for basal insulin treatment in type 2 diabetes mellitus. Clin Ther 2004;26:889-901. [PMID: 15262459 DOI: 10.1016/s0149-2918(04)90132-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
626 Lapolla A, Tubaro M, Fedele D, Reitano R, Aricò NC, Ragazzi E, Seraglia R, Vogliardi S, Traldi P. A matrix-assisted laser desorption/ionization mass spectrometry study of the non-enzymatic glycation products of human globins in diabetes: Glycation products of human globins in diabetes. Rapid Commun Mass Spectrom 2005;19:162-8. [DOI: 10.1002/rcm.1759] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
627 Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. Journal of Cystic Fibrosis 2004;3:209-22. [DOI: 10.1016/j.jcf.2004.08.001] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 4.7] [Reference Citation Analysis]
628 Cely CM, Arora P, Quartin AA, Kett DH, Schein RM. Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. Chest. 2004;126:879-887. [PMID: 15364770 DOI: 10.1378/chest.126.3.879] [Cited by in Crossref: 83] [Cited by in F6Publishing: 87] [Article Influence: 4.4] [Reference Citation Analysis]
629 Lapolla A, Tubaro M, Reitano R, Aricò NC, Ragazzi E, Seraglia R, Vogliardi S, Traldi P, Fedele D. The complexity of non-enzymatic glycation product sets of human globins. Diabetologia 2004;47:1712-5. [PMID: 15549235 DOI: 10.1007/s00125-004-1512-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
630 Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med. 2004;21:657-665. [PMID: 15209755 DOI: 10.1046/j.1464-5491.2003.01065.x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 165] [Article Influence: 8.4] [Reference Citation Analysis]
631 Misciagna G, Logroscino G, De Michele G, Cisternino AM, Guerra V, Freudenheim JL. Fructosamine, glycated hemoglobin, and dietary carbohydrates. Clin Chim Acta 2004;340:139-47. [PMID: 14734205 DOI: 10.1016/j.cccn.2003.10.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
632 Herrera Pombo J, Sánchez-vilar O. Diabetes mellitus tipo 2. Manifestaciones clínicas y seguimiento. Referencia a la medicina especializada. Medicine - Programa de Formación Médica Continuada Acreditado 2004;9:981-989. [DOI: 10.1016/s0211-3449(04)70146-0] [Reference Citation Analysis]
633 Diabetes Research In Children Network (Direcnet) Study Group. A multicenter study of the accuracy of the One Touch Ultra home glucose meter in children with type 1 diabetes. Diabetes Technol Ther 2003;5:933-41. [PMID: 14709195 DOI: 10.1089/152091503322640971] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 2.2] [Reference Citation Analysis]
634 Lahousen T, Hegenbarth K, Ille R, Lipp RW, Krause R, Little RR, Schnedl WJ. Determination of glycated hemoglobin in patients with advanced liver disease. World J Gastroenterol 2004; 10(15): 2284-2286 [PMID: 15259084 DOI: 10.3748/wjg.v10.i15.2284] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
635 Hillman N, Herranz L, Grande C, Vaquero PM, Pallardo LF. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes? Diabet Med 2004;21:468-70. [PMID: 15089792 DOI: 10.1111/j.1464-5491.2004.01184.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
636 Murata GH, Hoffman RM, Wendel CS, Shah JH, Duckworth WC. Contributions of Weekly Mean Blood Glucose Values to Hemoglobin A1c in Insulin-Treated Type 2 Diabetes: The Diabetes Outcomes in Veterans Study (DOVES). The American Journal of the Medical Sciences 2004;327:319-23. [DOI: 10.1097/00000441-200406000-00004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
637 Manley S. Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003;41:1182-90. [PMID: 14598868 DOI: 10.1515/CCLM.2003.182] [Cited by in Crossref: 69] [Cited by in F6Publishing: 72] [Article Influence: 3.6] [Reference Citation Analysis]
638 Haeckel R, Wosniok W, Raber R, Janka HU. Detecting type 2 diabetes by a single post-challenge blood sample. Clin Chem Lab Med 2003;41:1251-8. [PMID: 14598878 DOI: 10.1515/CCLM.2003.192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
639 Camargo JL, Gross JL. Conditions associated with very low values of glycohaemoglobin measured by an HPLC method. J Clin Pathol 2004;57:346-9. [PMID: 15047733 DOI: 10.1136/jcp.2002.007088] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
640 Kilpatrick ES. HbA1c measurement. J Clin Pathol 2004;57:344-5. [PMID: 15047732 DOI: 10.1136/jcp.2003.010918] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
641 Charbonnel B, Bouhanick B, Le Feuvre C. Recommandations SFC/ALFEDIAM sur la prise en charge du patient diabétique vu par le cardiologue. Diabetes & Metabolism 2004;30:2S9-2S24. [DOI: 10.1016/s1262-3636(04)72799-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
642 Waldhäusl W. Selbstkontrolle. Diabetes in der Praxis 2004. [DOI: 10.1007/978-3-642-18571-7_19] [Reference Citation Analysis]
643 Huang Y, Mccullagh P, Black N, Harper R. Feature Selection and Classification Model Construction on Type 2 Diabetic Patient’s Data. Advances in Data Mining 2004. [DOI: 10.1007/978-3-540-30185-1_17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
644 Landgraf R. The relationship of postprandial glucose to HbA1c. Diabetes Metab Res Rev 2004;20:S9-S12. [DOI: 10.1002/dmrr.517] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.6] [Reference Citation Analysis]
645 Dukes JW, Chen AC, Jovanovic L. Diabetes in Pregnancy. Handbook of Clinical Laboratory Testing During Pregnancy 2004. [DOI: 10.1007/978-1-59259-787-1_17] [Reference Citation Analysis]
646 Truschnig-wilders M, Boehm BO, März W. Laboratoriumsdiagnostik bei Diabetes mellitus/Laboratory diagnostics in patients with diabetes mellitus. LaboratoriumsMedizin 2004;28:334-345. [DOI: 10.1515/labmed.2004.050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
647 Goldstein BJ, Jabbour S, Ahmed I. Glycated Hemoglobin and Serum Proteins as Tools for Monitoring. International Textbook of Diabetes Mellitus 2003. [DOI: 10.1002/0470862092.d0806] [Reference Citation Analysis]
648 Gross JL, Ferreira SR, Oliveira JED. Glicemia pós-prandial. Arq Bras Endocrinol Metab 2003;47:728-38. [DOI: 10.1590/s0004-27302003000600017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
649 Kilo C, Mezitis N, Jain R, Mersey J, Mcgill J, Raskin P. Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin. Journal of Diabetes and its Complications 2003;17:307-13. [DOI: 10.1016/s1056-8727(03)00076-x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 4.2] [Reference Citation Analysis]
650 Osei K, Rhinesmith S, Gaillard T, Schuster D. Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 2003;88:4596-601. [PMID: 14557428 DOI: 10.1210/jc.2003-030686] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 2.9] [Reference Citation Analysis]
651 García Soidán FJ. [Glycaemic risk and contribution of post-prandial glucaemia to glycosylated haemoglobin (HbA 1c )]. Aten Primaria 2003;31:191-3. [PMID: 12622987 DOI: 10.1016/s0212-6567(03)70681-7] [Reference Citation Analysis]
652 García Soidán F. Riesgo glucémico y contribución de la glucemia posprandial a la hemoglobina glucosilada (HbA1c). Atención Primaria 2003;31:1-6. [DOI: 10.1016/s0212-6567(03)70671-4] [Reference Citation Analysis]
653 American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S33-50. [PMID: 12502618 DOI: 10.2337/diacare.26.2007.s33] [Cited by in Crossref: 390] [Cited by in F6Publishing: 445] [Article Influence: 19.5] [Reference Citation Analysis]
654 Rohlfing C, Wiedmeyer H, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D. Biological Variation of Glycohemoglobin. Clinical Chemistry 2002;48:1116-8. [DOI: 10.1093/clinchem/48.7.1116] [Cited by in Crossref: 122] [Cited by in F6Publishing: 122] [Article Influence: 5.8] [Reference Citation Analysis]
655 . Current literature in diabetes. Diabetes Metab Res Rev 2002;18:245-52. [PMID: 12112943 DOI: 10.1002/dmrr.245] [Reference Citation Analysis]
656 Kang M, Peery AF, Locklear C, Galanko JA, Sandler RS, Keku TO. Plasma insulin, glucose, IGF-I, IGF-II, and IGFBP-3 and risk of recurrent colorectal adenomas. J Gastroenterol Hepatol Res 2013;2:531-5. [PMID: 24533351 DOI: 10.6051/j.issn.2224-3992.2013.02.247] [Cited by in F6Publishing: 3] [Reference Citation Analysis]